Kidney cancer in a 14-year-old child: a rare clinical case description ; Редкий случай наблюдения почечно-клеточного рака почки у ребёнка 14 лет

Authors: S. A. Kuznetsov, V. V. Sizonov, I. I. Belousov, A. S. Podrezova, С. А. Кузнецов, В. В. Сизонов, И. И. Белоусов, А. С. Подрезова

Contributors: The study was not sponsored, Исследование не имело спонсорской поддержки

Source: Urology Herald; Том 12, № 6 (2024); 59-66 ; Вестник урологии; Том 12, № 6 (2024); 59-66 ; 2308-6424 ; 10.21886/2308-6424-2024-12-6

Subject Terms: радикальная нефрэктомия, renal cell carcinoma, partial nephrectomy, radical nephrectomy, почечно-клеточный рак, резекция почки

File Description: application/pdf

Relation: https://www.urovest.ru/jour/article/view/981/612; Calandrini C, Schutgens F, Oka R, Margaritis T, Candelli T, Mathijsen L, Ammerlaan C, van Ineveld RL, Derakhshan S, de Haan S, Dolman E, Lijnzaad P, Custers L, Begthel H, Kerstens HHD, Visser LL, Rookmaaker M, Verhaar M, Tytgat GAM, Kemmeren P, de Krijger RR, Al-Saadi R, Pritchard-Jones K, Kool M, Rios AC, van den Heuvel-Eibrink MM, Molenaar JJ, van Boxtel R, Holstege FCP, Clevers H, Drost J. An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity. Nat Commun. 2020;11(1):1310. DOI:10.1038/s41467-020-15155-6; Brok J, Treger TD, Gooskens SL, van den Heuvel-Eibrink MM, Pritchard-Jones K. Biology and treatment of renal tumours in childhood. Eur J Cancer. 2016;68:179-195. DOI:10.1016/j.ejca.2016.09.005; Cajaiba MM, Dyer LM, Geller JI, Jennings LJ, George D, Kirschmann D, Rohan SM, Cost NG, Khanna G, Mullen EA, Dome JS, Fernandez CV, Perlman EJ. The classification of pediatric and young adult renal cell carcinomas registered on the children’s oncology group (COG) protocol AREN03B2 after focused genetic testing. Cancer. 2018;124(16):3381-3389. DOI:10.1002/cncr.31578; Ginsburg KB, Johnson K, Moldovan T, Peabody H, Qi J, Dunn RL, Rogers C, Weizer A, Kaul S, Johnson A, Traver M, Lane BR; Michigan Urological Surgery Improvement Collaborative. A Statewide Quality Improvement Collaborative’s Adherence to the 2017 American Urological Association Guidelines Regarding Initial Evaluation of Patients With Clinical T1 Renal Masses. Urology. 2021;158:117-124. DOI:10.1016/j.urology.2021.08.036; Schieda N, Vakili M, Dilauro M, Hodgdon T, Flood TA, Shabana WM. Solid Renal Cell Carcinoma Measuring Water Attenuation (-10 to 20 HU) on Unenhanced CT. AJR Am J Roentgenol. 2015;205(6):1215-1221. Erratum in: AJR Am J Roentgenol. 2016;206(4):901. DOI:10.2214/AJR.15.14554.; Gobara A, Yoshizako T, Yoshida R, Katsube T, Ishikura Y, Kamimura T, Kaji Y. Radiological Features of T1a Renal Cell Carcinoma on Axial Unenhanced Computed Tomography. Cureus. 2023;15(3):e36881. DOI:10.7759/cureus.36881; Jonisch AI, Rubinowitz AN, Mutalik PG, Israel GM. Can high-attenuation renal cysts be differentiated from renal cell carcinoma at unenhanced CT? Radiology. 2007;243(2):445-450. DOI:10.1148/radiol.2432060559; Ljungberg B, Albiges L, Abu-Ghanem Y, Bedke J, Capitanio U, Dabestani S, Fernández-Pello S, Giles RH, Hofmann F, Hora M, Klatte T, Kuusk T, Lam TB, Marconi L, Powles T, Tahbaz R, Volpe A, Bex A. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. Eur Urol. 2022;82(4):399-410. DOI:10.1016/j.eururo.2022.03.006; Burnand K, Roberts A, Bouty A, Nightingale M, Campbell M, Heloury Y. Laparoscopic nephrectomy for Wilms’ tumor: Can we expand on the current SIOP criteria? J Pediatr Urol. 2018;14(3):253.e1-253.e8. DOI:10.1016/j.jpurol.2018.01.005; Kim SP, Murad MH, Thompson RH, Boorjian SA, Weight CJ, Han LC, Erwin PJ, Costello BA, Chow GK, Leibovich BC. Comparative Effectiveness for Survival and Renal Function of Partial and Radical Nephrectomy for Localized Renal Tumors : A Systematic Review and Meta-Analysis. J Urol. 2012:S0022-5347(12)05254-8. Epub ahead of print. DOI:10.1016/j.juro.2012.10.026; Indolfi P, Terenziani M, Casale F, Carli M, Bisogno G, Schiavetti A, Mancini A, Rondelli R, Pession A, Jenkner A, Pierani P, Tamaro P, De Bernardi B, Ferrari A, Santoro N, Giuliano M, Cecchetto G, Piva L, Surico G, Di Tullio MT. Renal cell carcinoma in children: a clinicopathologic study. J Clin Oncol. 2003;21(3):530-535. DOI:10.1200/JCO.2003.02.072; Indolfi P, Bisogno G, Cecchetto G, Spreafico F, De Salvo GL, Collini P, Jenkner A, Inserra A, Schiavetti A, di Martino M, Casale F. Local lymph node involvement in pediatric renal cell carcinoma: a report from the Italian TREP project. Pediatr Blood Cancer. 2008;51(4):475-478. DOI:10.1002/pbc.21652; Motzer RJ, Bander NH, Nanus DM. Renal-cell carcinoma. N Engl J Med. 1996;335(12):865-875. DOI:10.1056/NEJM199609193351207; Geller JI, Cost NG, Chi YY, Tornwall B, Cajaiba M, Perlman EJ, Kim Y, Mullen EA, Glick RD, Khanna G, Daw NC, Ehrlich P, Fernandez CV, Dome JS; Children’s Oncology Group (COG) Renal Tumor Committee. A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children’s Oncology Group AREN0321 study. Cancer. 2020;126(23):5156-5164. DOI:10.1002/cncr.33173; Abdellah A, Selma K, Elamin M, Asmae T, Lamia R, Abderrahmane M, Sanaa el M, Hanan E, Tayeb K, Noureddine B. Renal cell carcinoma in children: case report and literature review. Pan Afr Med J. 2015;20:84. DOI:10.11604/pamj.2015.20.84.5791; https://www.urovest.ru/jour/article/view/981

Availability: https://www.urovest.ru/jour/article/view/981
https://doi.org/10.21886/2308-6424-2024-12-6-59-66

Collecting duct (Bellini duct) renal cell carcinoma: a clinical case and literature review ; Карцинома собирательных трубочек Bellini: клинический случай и обзор литературных данных

Authors: N. I. Sorokin, V. E. Sinitsyn, O. A. Kharlova, A. A. Strigunov, O. Yu. Nesterova, R. A. Nikoghosyan, E. A. Galliamov, A. A. Kamalov, Н. И. Сорокин, В. Е. Синицын, О. А. Харлова, А. А. Стригунов, О. Ю. Нестерова, Р. А. Никогосян, Э. А. Галлямов, А. А. Камалов

Source: Urology Herald; Том 12, № 2 (2024); 108-119 ; Вестник урологии; Том 12, № 2 (2024); 108-119 ; 2308-6424 ; 10.21886/2308-6424-2024-12-2

Subject Terms: радикальная нефрэктомия, collecting duct (Bellini duct) renal cell carcinoma, partial nephrectomy, radical nephrectomy, рак протоков Bellini, резекция почки

File Description: application/pdf

Relation: https://www.urovest.ru/jour/article/view/859/554; Андреева Ю.Ю., Данилова Н.В., Москвина Л.В., Завалишина Л.Э., Кекеева Т.В., Мальков П.Г., Франк Г.А. Опухоли мочевыделительной системы и мужских половых органов. Морфологическая диагностика и генетика: Руководство для врачей. Москва: Практическая медицина; 2012.; Sui W, Matulay JT, Robins DJ, James MB, Onyeji IC, Roy-Choudhury A, Wenske S, DeCastro GJ. Collecting duct carcinoma of the kidney: Disease characteristics and treatment outcomes from the National Cancer Database. Urol Oncol. 2017;35(9):540.e13-540.e18. DOI:10.1016/j.urolonc.2017.04.010; Tang C, Zhou Y, Ge S, Yi X, Lv H, Zhou W. Incidence, Clinical Characteristics, and Survival of Collecting Duct Carcinoma of the Kidney: A Population-Based Study. Front Oncol. 2021;11:727222. DOI:10.3389/fonc.2021.727222; Cromie WJ, Davis CJ, DeTure FA. Atypical carcinoma of kidney: possibly originating from collecting duct epithelium. Urology. 1979;13(3):315-317. DOI:10.1016/0090-4295(79)90434-5; Fleming S, Lewi HJ. Collecting duct carcinoma of the kidney. Histopathology. 1986;10(11):1131-1141. DOI:10.1111/j.1365-2559.1986.tb02553.x; Karakiewicz PI, Trinh QD, Rioux-Leclercq N, de la Taille A, Novara G, Tostain J, Cindolo L, Ficarra V, Artibani W, Schips L, Zigeuner R, Mulders PF, Lechevallier E, Coulange C, Valeri A, Descotes JL, Rambeaud JJ, Abbou CC, Lang H, Jacqmin D, Mejean A, Patard JJ. Collecting duct renal cell carcinoma: a matched analysis of 41 cases. Eur Urol. 2007;52(4):1140-1145. DOI:10.1016/j.eururo.2007.01.070; Tokuda N, Naito S, Matsuzaki O, Nagashima Y, Ozono S, Igarashi T; Japanese Society of Renal Cancer. Collecting duct (Bellini duct) renal cell carcinoma: a nationwide survey in Japan. J Urol. 2006;176(1):40-43; discussion 43. DOI:10.1016/S0022-5347(06)00502-7; Cabanillas G, Montoya-Cerrillo D, Kryvenko ON, Pal SK, Arias-Stella JA 3rd. Collecting duct carcinoma of the kidney: diagnosis and implications for management. Urol Oncol. 2022;40(12):525-536. DOI:10.1016/j.urolonc.2021.04.041; Yin M, Wang W, Rosenberg J, Kaag M, Joshi M, Holder S, Tuanquin L, Drabick JJ. Targeted Therapy in Collecting Duct Carcinoma of the Kidney: A Case Report and Literature Review. Clin Genitourin Cancer. 2016;14(2):e203-e206. DOI:10.1016/j.clgc.2015.11.008; Ciszewski S, Jakimów A, Smolska-Ciszewska B. Collecting (Bellini) duct carcinoma: A clinical study of a rare tumour and review of the literature. Can Urol Assoc J. 2015;9(9-10):E589-E593. DOI:10.5489/cuaj.2932; Singh I, Nabi G. Bellini duct carcinoma: review of diagnosis and management. Int Urol Nephrol. 2002;34(1):91-95. DOI:10.1023/a:1021315130481; Zhou JX, He XR, Song GX, Zou ZG, Wang LH, Hu R, Li HX. [Clinicopathologic features with collecting duct carcinoma of kidney: report of 10 cases]. Zhonghua Bing Li Xue Za Zhi. 2018;47(2):123-127. (In Chinese) DOI:10.3760/cma.j.issn.0529-5807.2018.02.009; Chen J, Cai D, Gong K, Zhu S. Collecting Duct Carcinoma of the Kidney: Analysis of 74 Cases From Multiple Centers. Urology. 2022;164:163-168. DOI:10.1016/j.urology.2022.01.032; Pickhardt PJ, Siegel CL, McLarney JK. Collecting duct carcinoma of the kidney: are imaging findings suggestive of the diagnosis? AJR Am J Roentgenol. 2001;176(3):627-633. DOI:10.2214/ajr.176.3.1760627; Wang L, Peng L, Hou T, Shi Y. Renal collecting duct carcinoma: report of a case with unusual imaging findings regarding renal function. J Cancer Res Ther. 2013;9(2):331-333. DOI:10.4103/0973-1482.113425; Vanderbruggen W, Claessens M, De Coninck V, Duchateau A, Gevaert T, Joniau S, Hente R. Collecting duct renal cell carcinoma: a single centre series and review of the literature. Cent European J Urol. 2022;75(3):252-256. DOI:10.5173/ceju.2022.0143; Xie Z, Yadav S, Lohse CM, Cheville JC, Pagliaro LC, Shah PH, Boorjian SA, Thompson H, Leibovich BC, Costello BA. Collecting duct carcinoma: A single-institution retrospective study. Urol Oncol. 2022;40(1):13.e9-13.e18. DOI:10.1016/j.urolonc.2021.09.019; Pal SK, Choueiri TK, Wang K, Khaira D, Karam JA, Van Allen E, Palma NA, Stein MN, Johnson A, Squillace R, Elvin JA, Chmielecki J, Yelensky R, Yakirevich E, Lipson D, Lin DI, Miller VA, Stephens PJ, Ali SM, Ross JS. Characterization of Clinical Cases of Collecting Duct Carcinoma of the Kidney Assessed by Comprehensive Genomic Profiling. Eur Urol. 2016;70(3):516-521. DOI:10.1016/j.eururo.2015.06.019; Wang J, Papanicolau-Sengos A, Chintala S, Wei L, Liu B, Hu Q, Miles KM, Conroy JM, Glenn ST, Costantini M, Magi-Galluzzi C, Signoretti S, Choueiri T, Gallucci M, Sentinelli S, Fazio VM, Poeta ML, Liu S, Morrison C, Pili R. Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation. Oncotarget. 2016;7(21):29901-29915. DOI:10.18632/oncotarget.9093; Qian X, Wang Z, Zhang J, Wang Q, Zhou P, Wang S, Wang B, Qian C. Clinical Features and Prognostic Outcome of Renal Collecting Duct Carcinoma: 12 Cases from a Single Institution. Cancer Manag Res. 2020;12:3589-3595. DOI:10.2147/CMAR.S244094; Gollob JA, Upton MP, DeWolf WC, Atkins MB. Long-term remission in a patient with metastatic collecting duct carcinoma treated with taxol/carboplatin and surgery. Urology. 2001;58(6):1058. DOI:10.1016/s0090-4295(01)01411-x; Oudard S, Banu E, Vieillefond A, Fournier L, Priou F, Medioni J, Banu A, Duclos B, Rolland F, Escudier B, Arakelyan N, Culine S; GETUG (Groupe d'Etudes des Tumeurs Uro-Génitales). Prospective multicenter phase II study of gemcitabine plus platinum salt for metastatic collecting duct carcinoma: results of a GETUG (Groupe d'Etudes des Tumeurs Uro-Génitales) study. J Urol. 2007;177(5):1698-1702. DOI:10.1016/j.juro.2007.01.063; Rizzo M, Chiellino S, Gernone A, Porta C. Cisplatin-based chemotherapy for the treatment of metastatic collecting duct carcinomas: A real-world, retrospective analysis. Front Oncol. 2022;12:939953. DOI:10.3389/fonc.2022.939953; Houmaidi AE, Aynaou M, Mhanna T, Dua Boating P, Chennoufi M, Barki A. A huge collecting duct carcinoma of the kidney in an elderly woman: Diagnosis and managment challenge (uncommon condition). Urol Case Rep. 2020;33:101375. DOI:10.1016/j.eucr.2020.101375; Chao D, Zisman A, Pantuck AJ, Gitlitz BJ, Freedland SJ, Said JW, Figlin RA, Belldegrun AS. Collecting duct renal cell carcinoma: clinical study of a rare tumor. J Urol. 2002;167(1):71-74. DOI:10.1016/s0022-5347(05)65385-2; Fuu T, Iijima K, Kusama Y, Otsuki T, Kato H. Complete response to combination therapy using nivolumab and ipilimumab for metastatic, sarcomatoid collecting duct carcinoma presenting with high expression of programmed death-ligand 1: a case report. J Med Case Rep. 2022;16(1):193. DOI:10.1186/s13256-022-03426-3; Xiao R, Liu C, He W, Ma L. Prognostic Factors and a Nomogram Predicting Overall Survival and Cancer-Specific Survival for Patients with Collecting Duct Renal Cell Carcinoma. Biomed Res Int. 2021;2021:6736008. DOI:10.1155/2021/6736008; https://www.urovest.ru/jour/article/view/859

Availability: https://www.urovest.ru/jour/article/view/859
https://doi.org/10.21886/2308-6424-2024-12-2-108-119

Acute kidney injury and its predictors in surgery of malignant kidney tumors ; Острое почечное повреждение и его предикторы при хирургии злокачественных новообразований почки

Authors: K. V. Pozdnyakov, S. A. Rakul, R. A. Eloev, K. A. Lukinov, К. В. Поздняков, С. А. Ракул, Р. А. Елоев, К. А. Лукинов

Source: Cancer Urology; Том 19, № 3 (2023); 19-28 ; Онкоурология; Том 19, № 3 (2023); 19-28 ; 1996-1812 ; 1726-9776

Subject Terms: острое почечное повреждение, partial nephrectomy, radical nephrectomy, acute kidney injury, резекция почки, радикальная нефрэктомия

File Description: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/1594/1476; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1594/1175; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1594/1176; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1594/1177; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1594/1178; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1594/1179; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1594/1180; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1594/1181; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1594/1182; Аксель Е.М., Матвеев В.Б. Статистика злокачественных новообразований мочевых и мужских половых органов в России и странах бывшего СССР. Онкоурология 2019;15(2):15–24. DOI:10.17650/1726-9776-2019-15-2-15-24; Ljungberg B., Bensalah K., Canfield S. et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 2015;67(5):913–24. DOI:10.1016/j.eururo.2015.01.005; Campbell S., Uzzo R.G., Allaf M.E. et al. Renal mass and localized renal cancer: AUA guideline. J Urol 2017;198(3):520–9. DOI:10.1016/j.juro.2017.04.100; Ракул С.А., Поздняков К.В., Елоев Р.А. Отдаленные онкологические результаты хирургического лечения локализованных опухолей почек. Онкоурология 2021;17(4):27–37. DOI:10.17650/1726-9776-2021-17-4-27-37; Kim S.P., Campbell S.C., Gill I. et al. Collaborative review of risk benefit trade-offs between partial and radical nephrectomy in the management of anatomically complex renal masses. Eur Urol 2017;72(1):64–75. DOI:10.1016/j.eururo.2016.11.038; Kim S.P., Thompson R.H., Boorjian S.A. et al. Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. J Urol 2012;188(1):51–7. DOI:10.1016/j.juro.2012.03.006; Соколов Д.В., Полушин Ю.С. Острое почечное повреждение в периоперационном периоде. Вестник анестезиологии и реаниматологии 2018;15(1):46–54. DOI:10.21292/2078-5658-2018-15-1-46-54; Chawla L.S., Eggers P.W., Star R.A. et al. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med 2014;371(1):58–66. DOI:10.1056/NEJMra1214243; Bellomo R., Ronco C., Kellum J.A. et al. Acute Dialysis Quality Initiative workgroup. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8(4):204–12. DOI:10.1186/cc2872; Mehta R.L., Kellum J.A., Shah S.V. et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11(2):31. DOI:10.1186/cc5713; Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 2012;120(4):179–84. DOI:10.1159/000339789; Thomas A.A., Demirjian S., Lane B.R. et al. Acute kidney injury: novel biomarkers and potential utility for patient care in urology. Urology 2011;77(1):5–11. DOI:10.1016/j.urology.2010.05.004; Thompson R.H., Lane B.R., Lohse CM. et al. Renal function after partial nephrectomy: effect of warm ischemia relative to quantity and quality of preserved kidney. Urology 2012;79(2):356–60. DOI:10.1016/j.urology.2011.10.031; Lane B.R., Russo P., Uzzo R.G. et al. Comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys reveals predominant role of nonmodifiable factors in determining ultimate renal function. J Urol 2011;185(2):421–7. DOI:10.1016/j.juro.2010.09.131; Zhang Z., Zhao J., Dong W. et al. Acute kidney injury after partial nephrectomy: role of parenchymal mass reduction and ischemia and impact on subsequent functional recovery. Eur Urol 2016;69(4): 745–52. DOI:10.1016/j.eururo.2015.10.023; National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;9(2 Suppl 1):1–266.; Bravi C.A., Vertosick E., Benfante N. et al. Impact of acute kidney injury and its duration on long-term renal function after partial nephrectomy. Eur Urol 2019;76(3):398–403. DOI:10.1016/j.eururo.2019.04.040; Suer E., Akpinar C., Izol V. et al. Predicting factors of acute kidney injury after partial nephrectomy and its impact on long-term renal function: a multicentre study of the Turkish Urooncology Association. Int J Clin Pract 2021;75(11). DOI:10.1111/ijcp.14751; Zhu K., Song H., Zhang Z. et al. Acute kidney injury in solitary kidney patients after partial nephrectomy: incidence, risk factors and prediction. Transl Androl Urol 2020;9(3):1232–43. DOI:10.21037/tau.2020.03.45; Volpe A., Blute M.L., Ficarra V. et al. Renal ischemia and function after partial nephrectomy: a collaborative review of the literature. Eur Urol 2015;68(1):61–74. DOI:10.1016/j.eururo.2015.01.025; Parekh D.J., Weinberg J.M., Ercole B. et al. Tolerance of the human kidney to isolated controlled ischemia. J Am Soc Nephrol 2013;24(3):506–17. DOI:10.1681/ASN.2012080786; Wahlberg E., Di Muzio P.J., Stoney R.J. et al. Aortic clamping during elective operations for infrarenal disease: the influence of clamping time on renal function. J Vasc Surg 2002;36(1):13–8. DOI:10.1067/mva.2002.123679; Xiong L., Nguyen J.K., Peng Y. et al. What happens to the preserved renal parenchyma after clamped partial nephrectomy? Eur Urol 2022;81(5):492–500. DOI:10.1016/j.eururo.2021.12.036; Antonelli A., Cindolo L., Sandri M. et al. Is off-clamp robot-assisted partial nephrectomy beneficial for renal function? Data from the CLOCK trial. BJU Int 2022;129(2):217–24. DOI:10.1111/bju.15503; Zabell J., Isharwal S., Dong W. et al. Acute kidney injury after partial nephrectomy of solitary kidneys: impact on long-term stability of renal function. J Urol 2018;200(6):1295–301. DOI:10.1016/j.juro.2018.07.042; Kim N.Y., Hong J.H., Koh D.H. et al. Effect of diabetes mellitus on acute kidney injury after minimally invasive partial nephrectomy: a case-matched retrospective analysis. J Clin Med 2019;8(4):468. DOI:10.3390/jcm8040468; https://oncourology.abvpress.ru/oncur/article/view/1594

Availability: https://oncourology.abvpress.ru/oncur/article/view/1594
https://doi.org/10.17650/1726-9776-2023-19-3-19-28

Results of surgical treatment of malignant kidney tumors based on the materials of urology departments of the Siberian State Medical University clinics ; Результаты хирургического лечения злокачественных опухолей почки по материалам урологического отделения клиник СибГМУ

Authors: V. R. Latypov, V. S. Popov, V. N. Latypova, S. I. Novikov, D. B. Akhmedov, O. S. Zebzeeva, В. Р. Латыпов, О. С. Попов, В. Н. Латыпова, С. И. Новиков, Д. Б. Ахмедов, О. С. Зебзеева

Contributors: The study was performed without external funding., Исследование проведено без спонсорской поддержки.

Source: Cancer Urology; Том 18, № 4 (2022); 25-32 ; Онкоурология; Том 18, № 4 (2022); 25-32 ; 1996-1812 ; 1726-9776

Subject Terms: удаление тромба нижней полой вены, kidney resection, radical nephrectomy, inferior vena cava thrombus, inferior vena cava thrombus removal, резекция почки, радикальная нефрэктомия, тромб нижней полой вены

File Description: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/1491/1413; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1491/1027; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1491/1028; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1491/1029; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1491/1030; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1491/1031; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1491/1032; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1491/1033; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1491/1034; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1491/1035; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1491/1036; Клиническая онкоурология. Под ред. Б.П. Матвеева. М.: АБВ-пресс, 2011.; Chen W., Zheng R., Baade P.D. et al. Cancer statistics in China, 2015. CA Cancer J Clin 2016;66(2):115–32. DOI:10.3322/caac.21338; Hötker A.M., Karlo C.A., Zheng J. et al. Clear cell renal cell carcinoma: associations between CT features and patient survival. AJR Am J Roentgenol 2016;206(5):1023–30. DOI:10.2214/AJR.15.15369; Rini B.I., Campbell S.C., Escudier B. Renal cell carcinoma. Lancet 2009;373(9669):1119–32. DOI:10.1016/S0140-6736(09)60229-4; Mirza М. Management of small renal masses in the older adult. Clin Geriatr Med 2015;31(4):603–13. DOI:10.1016/j.cger.2015.06.005; Guidelines. European Association of Urology, 2020.; Матвеев В.Б., Маркова А.С. Рак почки: что нового в 2018 году. Онкоурология 2018;14(4):48–52. DOI:10.17650/1726-9776-2018-14-4-48-52; Humphrey P.A., Moch H., Cubilla A.L. et al. The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: prostate and bladder tumours. Eur Urol 2016;70(1):106–19. DOI:10.1016/j.eururo.2016.02.028; Liungberg B., Bensalah K., Canfield S. et al. EAU guidelines on renal cell carcinoma. Eur Urol 2015;67(5):913–24. DOI:10.1016/j.eururo.2015.01.005; Щукин Д.В., Илюхин Ю.А. Хирургия опухолевых тромбов нижней полой вены при раке почки. Белгород: Белгородская областная типография, 2007. 196 c.; Diagnosis and surgical management of renal tumors. Eds.: M.A. Gorin, M.E. Allaf. Springer International Publishing AG, part of Springer Nature, 2019.; Hsieh J.J., Purdue M.P., Signoretti S. et al. Renal cell carcinoma Nat Rev Dis Primers 2017;3:17009. DOI:10.1038/nrdp.2017.9; Jakubovskis M., Kojalo U., Steinbrekera B. et al. Renal cell carcinoma trends in Latvia: incidence, mortality, and survival rates. Population-based study. Cent European J Urol 2019;72(4):344–50. DOI:10.5173/ceju.2019.0018; Reix B., Bernhard J.C., Patard J.J. et al. Overall survival and oncological outcomes after partial nephrectomy and radical nephrectomy for cT2a renal tumors: a collaborative international study from the French kidney cancer research network UroCCR. Prog Urol 2018;28(3):146–55. DOI:10.1016/j.purol.2017.12.004; Давыдов М.И., Матвеев В.Б., Матвеев Б.П. Операции на нижней полой вене у больных раком почки. Материалы VI Российской онкологической конференции. Доступно по: http://www.rosoncoweb.ru/library/congress/ru/06/21.php.; Переверзев А.С. Хирургия опухолей почки и верхних мочевых путей. Харьков: Lora Medpharm, 1997. 392 c.; Lambert E.H., Pierorazio P.M., Shabsigh A. et al. Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus. Urology 2007;69(6):1054–8. DOI:10.1016/j.urology.2007.02.052; Gonzalez J., Gorin M.A., Garcia-Roig M., Ciancio G. Inferior vena cava resection and reconstruction: technical considerations in the surgical management of renal cell carcinoma with tumor thrombus. Urol Oncol 2014;32(1):34.e19–26. DOI:10.1016/j.urolonc.2013.01.004; Волкова М.И., Черняев В.А., Бегалиев А.К. и др. Безопасность перевязки левой почечной вены во время циркулярной резекции нижней полой вены у больных раком правой почки с опухолевым венозным тромбозом. Онкоурология 2018;14(4):30–6. DOI:10.17650/1726-9776-2018-14-4-30-36; Котов С.В., Кириенко А.И., Юсуфов А.Г. и др. Интраоперационные и онкологические результаты лечения пациентов с почечно-клеточным раком и распространением опухолевого тромба по венозной системе. Онкоурология 2018;14(1):57–67. DOI:10.17650/1726-9776-2018-14-1-57-67; https://oncourology.abvpress.ru/oncur/article/view/1491

Availability: https://oncourology.abvpress.ru/oncur/article/view/1491
https://doi.org/10.17650/1726-9776-2022-18-4-25-32

Clinical significance of clinicopathological features in predicting surgical treatment and risk of complications in renal cancer with venous tumor thrombosis ; Клиническое значение клинико-патологических особенностей в прогнозировании хирургического лечения и риска осложнений при раке почки с венозным опухолевым тромбозом

Authors: R. N. Komarov, L. M. Rapoport, M. Shao, D. O. Korolev, M. He, R. I. Slusarenko, I. B. Lutsenko, Р. Н. Комаров, Л. М. Рапопорт, М. Шао, Д. О. Королев, М. Хэ, Р. И. Слусаренко, И. В. Луценко

Source: Andrology and Genital Surgery; Том 24, № 4 (2023); 128-134 ; Андрология и генитальная хирургия; Том 24, № 4 (2023); 128-134 ; 2412-8902 ; 2070-9781

Subject Terms: прогностические факторы, radical nephrectomy, venous thrombectomy, prognostic factors, радикальная нефрэктомия, венозная тромбэктомия

File Description: application/pdf

Relation: https://agx.abvpress.ru/jour/article/view/713/558; Jalil R., Lamb B., Green J., Sevdalis N. P100 Streamlining the urology MDT meeting – survey results from a national sample. Eur Urol Suppl 2012;5(11):225.; Powell H.A., Baldwin D.R. Multidisciplinary team management in thoracic oncology: more than just a concept? Eur Respir J 2014;43(6):1776–86. DOI:10.1183/09031936.00150813; Zhao X., Li L., Liu Z. et al. Radical nephrectomy and inferior vena cava tumor thrombectomy for Mayo IV tumor thrombus: surgical techniques and clinical experience. J Mod Urol 2019;24(8):639–44.; Liu Z., Wang X., Zhou J. et al. Surgical effect and related prognositc factors in patients with renal cell carcinoma and venous tumor thrombus. J Clin Urol 2023;38(4):265–70.; Давыдов М.И., Матвеев В.Б., Волкова М.И. и др. Хирургическое лечение больных раком почки с массивной опухолевой инвазией нижней полой вены. Онкоурология 2017;13(1):27–36. DOI:10.17650/1726-9776-2017-13-1-27-36; Атдуев В.А., Амоев З.В., Данилов А.А. и др. Хирургическое лечение рака почки с протяженными тромбами нижней полой вены: осложнения и отдаленные результаты. Онкоурология 2017;13(1):37–44. DOI:10.17650/1726-9776-2017-13-1-37-44; Reese A.C., Whitson J.M., Meng M.V. Natural history of untreated renal cell carcinoma with venous tumor thrombus. Urol Oncol 2013;31(7):1305–9. DOI:10.1016/j.urolonc.2011.12.006; Zapała Ł., Sharma S., Kunc M. et al. Analysis of clinicopathological factors influencing survival in patients with renal cell carcinoma and venous tumor thrombus. J Clin Med 2021;10(17):3852. DOI:10.3390/jcm10173852; Chen Z., Yang F., Ge L. et al. Outcomes of renal cell carcinoma with associated venous tumor thrombus: experience from a large cohort and short time span in a single center. BMC Cancer 2021;21(1):766. DOI:10.1186/s12885-021-08508-x; Shiff B., Breau R.H., Mallick R. et al Prognostic significance of extent of venous tumor thrombus in patients with non-metastatic renal cell carcinoma: results from a Canadian multi-institutional collaborative. Urol Oncol 2021;39(12):836.e19–e27. DOI:10.1016/j.urolonc.2021.08.016; Master V.A., Ethun C.G., Kooby D.A. et al. The value of a cross-discipline team-based approach for resection of renal cell carcinoma with IVC tumor thrombus: a report of a large, contemporary, single-institution experience. J Surg Oncol 2018;118(8):1219–26. DOI:10.1002/jso.25271; Kirkali Z., Van Poppel H. A critical analysis of surgery for kidney cancer with vena cava invasion. Eur Urology 2007;52(3):658–62. DOI:10.1016/j.eururo.2007.05.009; https://agx.abvpress.ru/jour/article/view/713

Availability: https://agx.abvpress.ru/jour/article/view/713
https://doi.org/10.17650/2070-9781-2023-24-4-128-134

Long-term oncological results of surgical treatment of localized renal tumors ; Отдаленные онкологические результаты хирургического лечения локализованных опухолей почек

Authors: S. A. Rakul, K. V. Pozdnyakov, R. A. Eloev, С. А. Ракул, К. В. Поздняков, Р. А. Елоев

Source: Cancer Urology; Том 17, № 4 (2021); 27-37 ; Онкоурология; Том 17, № 4 (2021); 27-37 ; 1996-1812 ; 1726-9776

Subject Terms: выживаемость, partial nephrectomy, radical nephrectomy, long-term oncological results, survival, резекция почки, радикальная нефрэктомия, отдаленные онкологические результаты

File Description: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/1484/1325; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1484/1024; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1484/1025; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1484/1026; Аксель Е.М., Матвеев В.Б. Статистика злокачественных новообразований мочевых и мужских половых органов в России и странах бывшего СССР. Онкоурология 2019;15(2):15-24. DOI:10.17650/1726-9776-2019-15-2-15-24.; Состояние онкологической помощи населению России в 2017 году. Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М.: МНИОИ им. П.А. Герцена - филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2018. 236 с.; Ljungberg B., Bensalah K., Canfield S. et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 2015;67(5):913-24. DOI:10.1016/j.eururo.2015.01.005.; Campbell S., Uzzo R.G., Allaf M.E. et al. Renal mass and localized renal cancer: AUA guideline. J Urol 2017;198:520-9. DOI:10.1016/j.juro.2017.04.100.; Kim S.P., Campbell S.C., Gill I. et al. Collaborative review of risk benefit trade offs between partial and radical nephrectomy in the management of anatomically complex renal masses. Eur Urol 2017;72(1):64-75. DOI:10.1016/j.eururo.2016.11.038.; Kim S.P., Thompson R.H., Boorjian S.A. et al. Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. J Urol 2012;188(1):51-7. DOI:10.1016/j.juro.2012.03.006.; Capitanio U., Terrone C., Antonelli A. et al. Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function. Eur Urol 2015;67(4):683-9. DOI:10.1016/j.eururo.2014.09.027.; Wang D.C., Plante K., Stewart T. et al. Comparison of survival for partial vs. radical nephrectomy in young patients with T1a renal cell carcinoma treated at commission on cancer-accredited facilities and influence of comorbidities on treatment choice. Urol Oncol 2017;35(11):660.e9-15. DOI:10.1016/j.urolonc.2017.06.056.; Go A.S., Chertow G.M., Fan D. et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351(13):1296-305. DOI:10.1056/NEJMoa041031.; Van Poppel H., Da Pozzo L., Albrecht W. et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2011;59(4):543-52. DOI:10.1016/j.eururo.2010.12.013.; Koo K.C., Kim J.C., Cho K.S. et al. Oncological outcomes after partial vs radical nephrectomy in renal cell carcinomas of; Beauval J.B., Peyronnet B., Benoit T. et al. Long-term oncological outcomes after robotic partial nephrectomy for renal cell carcinoma: a prospective multicentre study. World J Urol 2018;36(6):897-904. DOI:10.1007/s00345-018-2208-8.; Jang H.A., Kim J.W., Byun S.S. et al. Oncologic and functional outcomes after partial nephrectomy versus radical nephrectomy in T1b renal cell carcinoma: a multicenter, matched case-control study in Korean patients. Cancer Res Treat 2016;48(2):612-20. DOI:10.4143/crt.2014.122.; Cai Y., Li H.Z., Zhang Y.S. Comparison of partial and radical laparoscopic nephrectomy: long-term outcomes for clinical T1b renal cell carcinoma. Urol J 2018;15(2):16-20. DOI:10.22037/uj.v0i0.3913.; Bertolo R., Autorino R., Simone G. et al. Outcomes of robot-assisted partial nephrectomy for clinical T2 renal tumors: a multicenter analysis (ROSULA Collaborative Group). Eur Urol 2018;74(2):226-32. DOI:10.1016/j.eururo.2018.05.004.; Kopp R.P., Mehrazin R., Palazzi K.R. et al. Survival outcomes after radical and partial nephrectomy for clinical T2 renal tumours categorised by R.E.N.A.L. nephrometry score. BJU Int 2014;114(5):708-18. DOI:10.1111/bju.12580.; https://oncourology.abvpress.ru/oncur/article/view/1484

Availability: https://oncourology.abvpress.ru/oncur/article/view/1484
https://doi.org/10.17650/1726-9776-2021-17-4-27-37

Surgical treatment of giant renal tumor: a case report ; Случай хирургического лечения гигантской злокачественной опухоли почки

Authors: V. R. Latypov, O. S. Popov, S. I. Novikov, V. N. Latypova, D. B. Ahmedov, В. Р. Латыпов, О. С. Попов, С. И. Новиков, В. Н. Латыпова, Д. Б. Ахмедов

Source: Cancer Urology; Том 17, № 3 (2021); 140-144 ; Онкоурология; Том 17, № 3 (2021); 140-144 ; 1996-1812 ; 1726-9776

Subject Terms: дифференциальная диагностика, renal cancer, radical nephrectomy of a large renal tumor, extraorgan tumor of the retroperitoneal space, differential diagnosis, почечно-клеточный рак, радикальная нефрэктомия большой почечной опухоли, внеорганная опухоль забрюшинного пространства

File Description: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/1429/1307; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1429/969; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1429/970; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1429/971; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1429/972; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1429/973; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1429/974; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1429/975; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1429/976; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1429/977; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1429/978; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1429/979; Рева И.А., Бормотин А.В., Дьяков В.В. и др. Опухоль почки крупных размеров, имитирующая внеорганную опухоль забрюшинного пространства: клинический случай. Онкоурология 2015;(1):64—7. DOI:10.17650/1726-9776-2015-1-64-67.; Oviedo R.J., Robertson J.C., Whithaus K. Surgical challenges in the treatment of a giant renal cell carcinoma with atypical presentation: a case report. Int J Surg Case Rep 2016;24:63-6. DOI:10.1016/j.ijscr.2016.05.010.; Takagi T., Sugihara T., Yasunaga H. et al. Cytoreductive nephrectomy for metastatic renal cell carcinoma: a population-based analysis of perioperative outcomes according to clinical stage. Int J Urol 2014;21(8):770-5. DOI:10.1111/iju.12446.; Wszolek M.F., Wotkowicz C., Libertino J.A. Surgical management of large renal tumors. Nat Clin Pract Urol 2008;5(1):35—46. DOI:10.1038/ncpuro0963.; Turkan S., Kalkan M., Basri §ener H. et al. Giant chromophobe renal cell carcinoma. J Case Rep 2015;5(1):5—7.; Suzuki K., Kubo T., Morita T. A giant chromophobe renal cell carcinoma exceeding 10 kg. Int J Urol 2009;16(12):976. DOI:10.1111/j.1442-2042.2009.02402.x.; Pramod S.V., Safriad F., Hernowo B.S. et al. A case report of one of the largest (9900 cm3) clear cell renal carcinoma removed in Asia. Urol Case Rep 2020;32:101208. DOI:10.1016/j.eucr.2020.101208.; Kogawa T., Kudoh T., Kawaguchi T. et al. Giant renal cell carcinoma: a case report. Nihon Gan Chiryo Gakkai Shi 1989;24(7):1467—71.; https://oncourology.abvpress.ru/oncur/article/view/1429

Availability: https://oncourology.abvpress.ru/oncur/article/view/1429
https://doi.org/10.17650/1726-9776-2021-17-3-140-144

Case report: robot-assisted extended radical nephrectomy with removal of conglomerate of the lymph nodes ; Клинический случай: робот-ассистированная расширенная радикальная нефрэктомия слева с удалением конгломерата лимфатических узлов

Authors: M. S. Mosoyan, D. A. Fedorov, N. A. Aysina, S. I. Tereshchenko, М. С. Мосоян, Д. А. Федоров, Н. А. Айсина, С. И. Терещенко

Source: Translational Medicine; Том 7, № 1 (2020); 70-75 ; Трансляционная медицина; Том 7, № 1 (2020); 70-75 ; 2410-5155 ; 2311-4495 ; 10.18705/2311-4495-2020-7-1

Subject Terms: эмболизация почечной артерии, radical nephrectomy, kidney cancer, conglomerate of the lymph nodes, renal artery embolization, радикальная нефрэктомия, рак почки, конгломерат лимфатических узлов

File Description: application/pdf

Relation: https://transmed.almazovcentre.ru/jour/article/view/541/370; Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.; Kaprin АD, Starinskiy VV, Petrova GV. Malignant tumors in Russia in 2017 (morbidity and mortality). Moscow: MNIOI im. P.A. Gertsena — filial FGBU “NMIRTS” Minzdrava Rossii, 2018. p. 250. In Russian [Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2017 году (заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена — филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2018. с. 250].; Kaprin АD, Starinskiy VV, Petrova GV. State of oncological care in Russia in 2017. Moscow: MNIOI im. P.A. Gertsena — filial FGBU “NMIRTS” Minzdrava Rossii, 2018. p. 236. In Russian [Каприн А.Д., Старинский В.В., Петрова Г.В. Состояние онкологической помощи населению России в 2017 году. М.: МНИОИ им. П.А. Герцена — филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2018. с. 236].; Rodriguez J, Smith Z, Packiam V et al. Roboticassistance is associated with improved perioperative outcomes in minimally-invasive radical nephrectomy. J Urol. 2018;199(4):e625.; Nazemi T, Galich A, Sterrett S et al. Radical nephrectomy performed by open, laparoscopy with or without hand-assistance or robotic methods by the same surgeon produces comparable perioperative results. Int Braz J Urol. 2006;32(1):15–22.; Mosoyan MS, Al-Shukri SKh, Semenov DYu. Robot assited laparoscopic nephrectomy and kidney resection: first experience (Methodic communication). Nefrologiya=Nephrology. 2012;16(1):63–65. In Russian [Мосоян М.С., Аль-Шукри С.Х., Семенов Д.Ю. Робот-ассистированная лапароскопическая нефрэктомия и резекция почки: первый опыт (методическое сообщение). Нефрология. 2012;16(1):63–65].; Al’-Shukri SKh, Mosoyan MS, Semenov DYu et al. Experience of 424 robot-assisted operations in St-Petersburg: radical prostatectomy, partial and radical nephrectomy. Vestnik hirurgii imeni I.I. Grekova=Grekov’s Bulletin of Surgery. 2016;175(5):74–77. In Russian [Аль-Шукри С.Х., Мосоян М.С., Семенов Д.Ю. и др. Опыт 424 робот-ассистированных вмешательств в Санкт-Петербурге: радикальная простатэктомия, резекция почки и нефрэктомия. Вестник хирургии имени И.И. Грекова. 2016;175(5):74–77].; Taccoen X, Valeri A, Descotes JL et al., Oncology Committee of the Association Française d’Urologie. Renal cell carcinoma in adults 40 years old or less: young age is an independent prognostic factor for cancer-specific survival. Eur Urol. 2007;51(4):980–987.; Zargar H, Addison B, McCall J et al. Renal artery embolization prior to nephrectomy for locally advanced renal cell carcinoma. ANZ J Surg. 2014;84(7–8):564–567.; Reinhart HA, Ghaleb M, Davis BR. Transarterial embolization of renal tumors improves surgical outcomes: a case series. Int J Surg Case Rep. 2015;15:116–118.; Khairy M, Othman MH, Ali EM et al. Preoperative embolization in surgical management of massive thoracic tumors. Asian Cardiovasc Thorac Ann. 2012;20(6):689–693.; https://transmed.almazovcentre.ru/jour/article/view/541

Availability: https://transmed.almazovcentre.ru/jour/article/view/541
https://doi.org/10.18705/2311-4495-2020-7-1-70-75

Surgical treatment of patients with renal cell cancer complicated by specific (tumor) and non-specific thrombosis of the inferior Vena cava ; Хирургическое лечение пациента с почечно-клеточным раком, осложненным специфическим (опухолевым) и неспецифическим тромбозом нижней полой вены

Authors: N. V. Vorobev, F. S. Ashyrova, M. P. Golovashchenko, L. O. Petrov, A. D. Kaprin, Н. В. Воробьев, Ф. С. Ашырова, М. П. Головащенко, Л. О. Петров, А. Д. Каприн

Source: Research and Practical Medicine Journal; Том 7, № 3 (2020); 91-98 ; Research'n Practical Medicine Journal; Том 7, № 3 (2020); 91-98 ; 2410-1893 ; 10.17709/2409-2231-2020-7-3

Subject Terms: клинический случай, radical nephrectomy, thrombectomy, inferior vena cava, iliac vein, thrombosis, clinical case, радикальная нефрэктомия, тромбэктомия, нижняя полая вена, подвздошная вена, тромбоз

File Description: application/pdf

Relation: https://www.rpmj.ru/rpmj/article/view/592/379; Давыдов М.И., Матвеев В.Б., Матвеев Б.П., Фигурин К.М., Буйденок П.И. Феоктистов Ю.М. Операции на нижней полой вене у больных раком почки. VI Российская онкологическая конференция. Материалы конгрессов и конференций, М., 2002:108–109. Доступно по: https://medvis.vidar.ru/jour/article/viewFile/248/249; Перлин Д.В., Зипунников В.П., Дымков И.Н., Шманев А.О., Попова М.Б. Лапароскопическая тромбэктомия из нижней полой вены с радикальной нефрэктомией при местно-распространенном почечноклеточном раке. Вестник урологии. 2016;(4):5–14.; Давыдов М.И., Матвеев В.Б., Волкова М.И., Фигурин К.М., Черняев А.В., Климов А.В. и др. Огородникова, С.М. Мхитарян. Резекция нижней полой вены у больных раком почки с массивным опухолевым венозным тромбозом. Журнал Онкоурология. 2018;14(2):15–25. https://doi.org/10.17650/1726-9776-2018-14-2-15-25; Hatcher PA, Anderson EE, Paulson DF, Carson CC, Robertson JE. Surgical management and prognosis of renal cell carcinoma invading the vena cava. J Urol. 1991 Jan;145(1):20–23; discussion 23-24. https://doi.org/10.1016/s0022-5347(17)38235-6; Shah PH, Thompson RH, Boorjian SA, Lohse CM, Lyon TD, Shields RC, et al. Symptomatic Venous Thromboembolism is Associated with Inferior Survival among Patients Undergoing Nephrectomy with Inferior Vena Cava Tumor Thrombectomy for Renal Cell Carcinoma. J Urol. 2018;200(3):520–527. https://doi.org/10.1016/j.juro.2018.04.069; Давыдов М.И., Матвеев В.Б., Волкова М.И., ФеоктистовП.И., Кузнецов К.П., Нехаев И.В. и др. Хирургическое лечение рака почки, осложненного опухолевым венозным тромбозом III– IV уровней. Журнал Онкоурология. 2016;12(4):21-34. https:// doi.org/10.17 650/1726-9776-2016-12-4-21-34; Campi R, Tellini R, Sessa F, Mari A, Cocci A, Greco F, et al. Techniques and outcomes of minimally-invasive surgery for nonmetastatic renal cell carcinoma with inferior vena cava thrombosis: a systematic review of the literature. Minerva Urol Nefrol. 2019 Aug;71(4):339–358. https://doi.org/10.23736/S0393-2249.19.03396-4; Perlin DV, Vorobiev AA, Zippunnikov VP, Dymkov IN. Left-sided renal cell cacrinoma with vena cava inferior thrombus: totally laparoscopic removal. Urologiia. 2018 Dec;(6):122–127.; Liu Z, Zhao X, Zhang H-X, Li L-W, Tang S-Y, Wang G-L, et al. Surgical complexity and prognostic outcome of small volume renal cell carcinoma with high-level venous tumor thrombus and large volume renal cell carcinoma with low-level thrombus. Chin Med J. 2019 Aug 5;132(15):1780–1787. https://doi.org/10.1097/CM9.0000000000000352; Wu JY, Mi Y, Liu S, Yao L, Tang Q, He ZS, et al. Evaluating inferior vena cava wall invasion in renal cell carcinoma tumor thrombus with MRI. Beijing Da Xue Xue Bao. 2019 Aug 18;51(4):673–677. https://doi.org/10.19723/j.issn.1671-167X.2019.04.013; Alayed A, Krishna S, Breau RH, Currin S, Flood TA, Narayanasamy S, et al. Diagnostic Accuracy of MRI for Detecting Inferior Vena Cava Wall Invasion in Renal Cell Carcinoma Tumor Thrombus Using Quantitative and Subjective Analysis. AJR Am J Roentgenol. 2019;212(3):562–569. https://doi.org/10.2214/AJR.18.20209; Rose KM, Navaratnam AK, Faraj KS, Abdul-Muhsin HM, Syal A, Elias L, et al. Comparison of Open and Robot Assisted Radical Nephrectomy with Level I and II Inferior Vena Cava Tumor Thrombus: The Mayo Clinic Experience. Urology. 2020 Feb;136:152–157. https://doi.org/10.1016/j.urology.2019.11.002; Ralla B, Adams L, Maxeiner A, Mang J, Krimphove M, Dushe , et al. Perioperative and oncologic outcome in patients treated for renal cell carcinoma with an extended inferior vena cava tumor thrombus level II-IV. Aktuelle Urol. 2019 Jun 4. https://doi.org/10.1055/a-0919-4043; Conti SL, Thomas I-C, Hagedorn JC, Chung BI, Chertow GM, Wagner TH, et al. Utilization of cytoreductive nephrectomy and patient survival in the targeted therapy era. Int J Cancer. 2014 May 1;134(9):2245–2252. https://doi.org/10.1002/ijc.28553; Reese AC, Whitson JM, Meng MV. Natural history of untreated renal cell carcinoma with venous tumor thrombus. Urol Oncol. 2013 Oct;31(7):1305–1309. https://doi.org/10.1016/j.urolonc.2011.12.006; Blute ML, Boorjian SA, Leibovich BC, Lohse CM, Frank I, Karnes RJ. Results of inferior vena caval interruption by greenfield filter, ligation or resection during radical nephrectomy and tumor thrombectomy. J Urol. 2007 Aug;178(2):440–445; discussion 444. https://doi.org/10.1016/j.juro.2007.03.121; https://www.rpmj.ru/rpmj/article/view/592

Availability: https://www.rpmj.ru/rpmj/article/view/592
https://doi.org/10.17709/2409-2231-2020-7-3-9

Influence of surgical approach on enhanced recovery after surgery in laparoscopic radical nephrectomy ; Влияние доступа на ускоренное восстановление после операции при лапароскопической радикальной нефрэктомии

Authors: D. V. Perlin, I. N. Dymkov, E. A. Davydova, A. O. Shmanev, A. V. Perlina, Д. В. Перлин, И. Н. Дымков, Е А Давыдова, А О Шманев, А В Перлина

Source: Cancer Urology; Том 16, № 1 (2020); 35-42 ; Онкоурология; Том 16, № 1 (2020); 35-42 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2020-16-1

Subject Terms: почечно-клеточный рак, laparoscopic radical nephrectomy, retroperitoneoscopic nephrectomy, renal cell carcinoma, реабилитация, послеоперационный период, лапароскопическая радикальная нефрэктомия, ретроперитонеоскопическая нефрэктомия

File Description: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/1010/1150; Алексеев Б.Я., Калпинский А.С., Воробьев Н.В. и др. Билатеральный рак почек. Онкология. Журнал им. П.А. Герцена 2016;5(1):55–62. DOI:10.17116/onkolog20165155-62.; Давыдов М.И., Матвеев В.Б., Волкова М.И. и др. Хирургическое лечение больных раком почки с массивной опухолевой инвазией нижней полой вены. Онкоурология 2017;13(1):27–36. DOI:10.17650/1726-9776-2017-13-1-27-36.; Zhang Z.L., Li Y.H., Luo J.H. et al. Complications of radical nephrectomy for renal cell carcinoma: a retrospective study comparing transperitoneal and retroperitoneal approaches using a standardized reporting methodology in two Chinese centers. Chin J Cancer 2013;32(8):461–8. DOI:10.5732/cjc.012.10185.; Ren T., Liu Y., Zhao X. et al. Transperitoneal approach versus retroperitoneal approach: a meta-analysis of laparoscopic partial nephrectomy for renal cell carcinoma. PLoS One 2014;9(3):e91978. DOI:10.1371/journal.pone.0091978.; Кадыров З.А., Султанов И.К., Одилов А.Ю. и др. Некоторые послеоперационные показатели традиционной и ретроперитонеоскопической нефрэктомии. Вестник Авиценны. 2013;1(54):41–5.; Okegawa T., Noda H., Horie S. et al. Comparison of transperitoneal and retroperitoneal laparoscopic nephrectomy for renal cell carcinoma: a single-center experience of 100 cases. Int J Urol 2008;15(11):957–60. DOI:10.1111/j.1442-2042.2008.02132.x.; Taue R., Izaki H., Koizumi T. et al. Transperitoneal versus retroperitoneal laparoscopic radical nephrectomy: a comparative study. Int J Urol 2008;16(3):263–7. DOI:10.1111/j.1442-2042.2008.02219.x.; Ha U., Hwang T., Kim Y. et al. Comparison of oncological outcomes of transperitoneal and retroperitoneal laparoscopic radical nephrectomy for the management of clear-cell renal cell carcinoma: a multi-institutional study. BJU Int 2010;107(9):1467–72. DOI:10.1111/j.1464-410x.2010.09636.x.; Cicco A., Salomon L., Hoznek A. et al. Results of retroperitoneal laparoscopic radical nephrectomy. J Endourol 2001;15(4):355–9. DOI:10.1089/089277901300189349.; Rassweiler J., Henkel T., Stoch C. et al. Retroperitoneal laparoscopic nephrectomy and other procedures in the upper retroperitoneum using a balloon dissection technique. Eur Urol 1994;25(3):229–36. DOI:10.1159/000475289.; Kerbl K., Figenshau R., Clayman R. et al. Retroperitoneal laparoscopic nephrectomy: laboratory and clinical experience. J Endourol 1993;7(1):23–6. DOI:10.1089/end.1993.7.23.; Liapis D., de la Taille A., Ploussard G. et al. Analysis of complications from 600 retroperitoneoscopic procedures of the upper urinary tract during the last 10 years. World J Urol 2008;26(6):523– 30. DOI:10.1007/s00345-008-0319-3.; Pakish J., Soliman P., Frumovitz M. et al. A comparison of extraperitoneal versus transperitoneal laparoscopic or robotic para-aortic lymphadenectomy for staging of endometrial carcinoma. Gynecol Oncol 2014;132(2):366–71. DOI:10.1016/j.ygyno.2013.12.019.; Iavazzo C., Gkegkes I. Robotic retroperitoneal lymph node dissection in gynaecological neoplasms: comparison of extraperitoneal and transperitoneal lymphadenectomy. Arch Gynecol Obstet 2015;293(1):11–28. DOI:10.1007/s00404-015-3814-y.; https://oncourology.abvpress.ru/oncur/article/view/1010

Availability: https://oncourology.abvpress.ru/oncur/article/view/1010
https://doi.org/10.17650/1726-9776-2020-16-1-35-42

COMPARATIVE ANALYSIS OF THE COURSE OF CHRONIC KIDNEY DISEASE (CKD) IN PATIENTS WITH DIFFERENT STAGES OF RENAL CANCER AFTER RADICAL AND CYTOREDUCTIVE NEPHRECTOMY ; СРАВНИТЕЛЬНЫЙ АНАЛИЗ ПРОТЕКАНИЯ ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК У БОЛЬНЫХ НА РАЗНЫХ СТАДИЯХ РАКА ПОСЛЕ РАДИКАЛЬНОЙ И ЦИТОРЕДУКТИВНОЙ НЕФРЭКТОМИИ ; ПОРІВНЯЛЬНИЙ АНАЛІЗ ПЕРЕБІГУ ХРОНІЧНОЇ ХВОРОБИ НИРОК У ХВОРИХ НА РІЗНИХ СТАДІЯХ РАКУ НИРКИ ПІСЛЯ РАДИКАЛЬНОЇ ТА ЦИТОРЕДУКТИВНОЇ НЕФРЕКТОМІЇ.

Authors: Pasichnyk, S. M., Dmytriv, V. J., Borys, Yu. B.

Source: Bulletin of Scientific Research; No 3 (2017) ; Вестник научных исследований; № 3 (2017) ; Вісник наукових досліджень; № 3 (2017) ; 2415-8798 ; 1681-276X ; 10.11603/2415-8798.2017.3

Subject Terms: kidney cancer, chronic kidney disease, radical nephrectomy, cytoreductive nephrectomy, рак почки, хроническая болезнь почек, радикальная нефрэктомия, циторедуктивная нефрэктомия, рак нирки, хронічна хвороба нирок, радикальна нефректомія, циторедуктивна нефректомія

File Description: application/pdf

Relation: https://ojs.tdmu.edu.ua/index.php/visnyk-nauk-dos/article/view/8088/7593; https://repository.tdmu.edu.ua//handle/123456789/12489

Availability: https://repository.tdmu.edu.ua//handle/123456789/12489
https://ojs.tdmu.edu.ua/index.php/visnyk-nauk-dos/article/view/8088
https://doi.org/10.11603/2415-8798.2017.3.8088

Review of the article “Laparoscopic management renal cell carcinoma in left kidney with tumor caval thrombus” ; Рецензия на статью «Лапароскопическая радикальная нефрэктомия с тромбэктомией из нижней полой вены при опухолевом тромбе из левой почки»

Authors: B. G. Guliev, Б. Г. Гулиев

Source: Cancer Urology; Том 15, № 1 (2019); 40-41 ; Онкоурология; Том 15, № 1 (2019); 40-41 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2019-15-1

Subject Terms: МОНОЦЕНТРОВОЕ ИССЛЕДОВАНИЕ, ЛАПАРОСКОПИЧЕСКАЯ РАДИКАЛЬНАЯ НЕФРЭКТОМИЯ, ТРОМБЭКТОМИЯ ИЗ НИЖНЕЙ ПОЛОЙ ВЕНЫ, ОПУХОЛЕВЫЙ ТРОМБ НИЖНЕЙ ПОЛОЙ ВЕНЫ

File Description: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/934/839; Давыдов М.И., Матвеев В.Б., Волкова М.И. и др. Хирургическое лечение больных раком почки с массивной опухолевой инвазией нижней полой вены. Онкоурология 2017;13(1):27—36. DOI:10.17650/1726-9776-2017-13-1-27-36.; Wang B., Li H., Ma X. et al. Robot-assisted laparoscopic inferior vena cava thrombectomy: different sides require different techniques. Eur Urol 2016;69(6):1112—9. DOI:10.1016/j.eururo.2015.12.001. PMID: 26706105.; Chopra S., Simone G., Metcalfe C. et al. Robot-assisted level II—III inferior vena cava tumor thrombectomy: step-by-step technique and 1-year outcomes. Eur Urol 2017;72(2):267-74. DOI:10.1016/j.eururo.2016.08.066. PMID: 27663048.; Nelson R.J., Maurice M.J., Kaouk J.H. Robotic radical left nephrectomy with inferior vena cava level III thrombectomy. Urology 2017;107:269. DOI:10.1016/j.urology.2017.04.043. PMID: 28982623.; Aghazadeh M.A., Goh A.C. Robotic left-sided level II caval thrombectomy and nephrectomy using a novel supine, single-dock approach: primary description. Urology 2018;112:205-8. DOI:10.1016/j.urology.2017.10.018. PMID: 29107130.; https://oncourology.abvpress.ru/oncur/article/view/934

Availability: https://oncourology.abvpress.ru/oncur/article/view/934
https://doi.org/10.17650/1726-9776-2019-15-1-40-41

Is technically complicated partial nephrectomy justified in renal cell carcinoma patients with normal contralateral kidney? ; Нужна ли технически сложная резекция больным опухолями почечной паренхимы с нормальной контрлатеральной почкой?

Authors: M. I. Volkova, V. A. Ridin, V. A. Cherniayev, A. V. Klimov, K. M. Figurin, A. A. Kirichek, V. B. Matveev, М. И. Волкова, В. А. Ридин, В. А. Черняев, А. В. Климов, К. М. Фигурин, А. А. Киричек, В. Б. Матвеев

Source: Cancer Urology; Том 15, № 4 (2019); 39-49 ; Онкоурология; Том 15, № 4 (2019); 39-49 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2019-15-4

Subject Terms: RENAL ≥7, radical nephrectomy, nephrometric index PADUA ≥8, радикальная нефрэктомия, нефрометрический индекс PADUA ≥8

File Description: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/979/893; Van Poppel H., Da Pozzo L., Albrecht W. et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephronsparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2011;59(4):543–52. DOI:10.1016/j.eururo.2010.12.013.; Dindo D., Demartines N., Clavien P.A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240(2):205–13. DOI:10.1097/01.sla.0000133083.54934.ae.; Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013;3:1–150.; Bellomo R., Ronco C., Kellum J.A. et al. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8(4):R204–12. DOI:10.1186/cc2872.; Lane B.R., Golan S., Eggener S. et al. Differential use of partial nephrectomy for intermediate and high complexity tumors may explain variability in reported utilization rates. J Urol 2013;189(6):2047–53. DOI:10.1016/j.juro.2013.01.007.; Lieser G., Simmons M.N. Developments in kidney tumor nephrometry. Postgrad Med 2011;123(3):35–42. DOI:10.3810/pgm.2011.05.2282.; Kunath F., Schmidt S., Krabbe L.M. et al. Partial nephrectomy versus radical nephrectomy for clinical localised renal masses. Cochrane Database Syst Rev 2017;5:CD012045. DOI:10.1002/14651858.CD012045.pub2.; Mir M.C., Derweesh I., Porpiglia F. et al. Partial nephrectomy versus radical nephrectomy for clinical T1b and T2 renal tumors: a systematic review and meta-analysis of comparative studies. Eur Urol 2017;71(4):606–17. DOI:10.1016/j.eururo.2016.08.060.; Scosyrev E., Messing E.M., Sylvester R. et al. Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904. Eur Urol 2014;65(2):372–7. DOI:10.1016/j.eururo.2013.06.044.; Go A.S., Chertow G.M., Fan D. et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351(13):1296– 305. DOI:10.1056/NEJMoa041031.; Weight C.J., Larson B.T., Fergany A.F. et al. Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses. J Urol 2010;183(4):1317–23. DOI:10.1016/j.juro.2009.12.030.; Волкова М.И., Скворцов И.Я., Климов А.В. и др. Влияние объема хирургического вмешательства на функциональные результаты и кардиоспецифическую выживаемость у больных клинически локализованным раком почки. Онкоурология 2014;(3):20–8.; Kim S.P., Thompson R.H., Boorjian S.A. et al. Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-аnalysis. J Urol 2012;188(1):51–7. DOI:10.1016/j.juro.2012.03.006.; Forbes C.M., Rendon R.A., Finelli A. et al. Disease progression and kidney function after partial vs. radical nephrectomy for T1 renal cancer. Urol Oncol 2016;34(11):486.e17–23. DOI:10.1016/j.urolonc.2016.05.034.; Kopp R.P., Mehrazin R., Palazzi K.L. et al. Survival outcomes after radical and partial nephrectomy for clinical T2 renal tumours categorised by R.E.N.A.L. nephrometry score. BJU Int 2014;114(5):708–18. DOI: 10.11.11/bju.12580.; https://oncourology.abvpress.ru/oncur/article/view/979

Availability: https://oncourology.abvpress.ru/oncur/article/view/979
https://doi.org/10.17650/1726-9776-2019-15-4-39-49

Evaluation of quality of life of patients after surgical treatment of kidney cancer ; Оценка качества жизни пациентов после хирургического лечения рака почки

Authors: S. V. Popov, R. G. Guseynov, I. N. Orlov, O. N. Skryabin, A. V. Davydov, R. S. Barkhitdinov, A. S. Katunin, M/ M. Mirzabekov, С. В. Попов, Р. Г. Гусейнов, И. Н. Орлов, О. Н. Скрябин, А. В. Давыдов, Р. С. Бархитдинов, А. С. Катунин, М. М. Мирзабеков

Source: Cancer Urology; Том 15, № 2 (2019); 25-34 ; Онкоурология; Том 15, № 2 (2019); 25-34 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2019-15-2

Subject Terms: лапароскопическая резекция почки, SF-36 questionnaire, localized kidney cancer, radical nephroectomy, laparoscopic resection of the kidney, опросник SF-36, локализованный рак почки, радикальная нефрэктомия

File Description: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/940/844; Рубанова Е.Ю. Теоретические аспекты качества жизни в контексте психологии здоровья. Ученые заметки ТОГУ 2014;5(3):108–15.; Новик А.А., Ионова Т.И. Руководство по исследованию качества жизни в медицине. М.: ОЛМА-ПРЕСС, 2002. 314 с.; Пойда А.И., Мельник В.М., Заверный Л.Г., Абу Шамсия Р.Н. Качество жизни больных, оперированных по поводу рака толстой кишки. Клиническая онкология 2011;специальный выпуск I:47–52.; Братславский Г., Борис Р. Новые возможности органосохраняющего лечения локализованного почечно-клеточного рака и его рецидивы. Злокачественные опухоли 2011;1:11–20.; Комягина Ю.М. Парциальная нефрэктомия при раке почки. Бюллетень медицинских интернет-конференций 2013;2:365.; Иванов П.М. Хирургическое лечение рака почки. Международный научноисследовательский журнал 2013;1:81–2.; Мосоян М.С., Аль-Шукри С.Х., Есаян А.М. и др. Резекция почки в условиях регионарной ишемии как средство обеспечения высокой онкологической выживаемости и низкого риска развития хронической болезни почек и сердечно-сосудистых заболеваний у пациентов с раком почки. Вестник Национального медикохирургического Центра им. Н.И. Пирогова 2013;8(2):42–7.; Шорманов И.С., Лось М.С., Чирков А.Н. Профилактика осложнений тотальной «тепловой ишемии» при резекции почки. Урологические ведомости 2015;5:34–5.; Смирнов А.В., Добронравов В.А., Бодур-Ооржак А.Ш. и др. Эпидемиология и факторы риска хронических болезней почек: региональный уровень общей проблемы. Терапевтический архив 2005;6:20–7.; Смирнов А.В., Добронравов В.А., Каюков И.Г. Кардиоренальный континуум: патогенетические основы превентивной нефрологии. Нефрология 2005;9(3):7–15.; Go A.S. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351(13):1296–305. DOI:10.1056/NEJMoa041031.; Campbell S.C. Guideline for management of the clinical T1 renal mass. J Urol 2009;182(4):1271–9. DOI:10.1016/j.juro.2009.07.004.; Состояние онкологической помощи населению России в 2017 году. Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2018. 236 с.; Krambek A.E., Gettman M.T., Rohlinger A.L. et al. Diabetes mellitus and hypertension associatеd with schock wave lithotripsy of renal and proximal ureteral stones at 19 years of following. J Urol 2006;175(5):1742–7. DOI:10.1016/S0022-5347(05)00989-4.; Eassa W.A., Sheir K.Z., Gad H.M. et al. Prospective study of the long-term effects of schock wave lithotripsy of renal functions and blood pressure. J Urol 2008;179(3): 964–8. DOI:10.1016/j.juro.2007.10.055.; Cracco C.M. ECIRS (Endoscopic Combined Intrarenal Surgery) in the Galdakaomodifed supine valdiva position: a new life for percutaneus surgery? World J Urol 2011;29:821.; Isak W. Endoscopic-gualed renal access for percutaneus nephrolithiatomy: a comparative analysis. Urology 2013;81:251–6.; Jessen J.P., Honeck P., Knoll T., WendtNordahl G. Percutaneus nephrolithiatomy under combined sonographic/radiologic guided puncture: results of a learning curve using the modified Clavien grading system. World J Urol 2013;31(6):1599–603. DOI:10.1007/s00345-012-1016-9.; Fankhauser C.D., Kranzbühler B., Poyet C. et al. Long-term adverse effects of extracorporeal shoch wave lithotripsy for nephrolithiasis and ureterolithiasis: a systematic review. Urology 2015;85(5):991–1006. DOI:10.1016/j.urology.2014.12.014.; Falahatkar S., Allahkhah A., Kazemzadeh M. et al. Complete supine PCNL: ultrasound vs. fluoroscopic guided: a randomized clinical trial. Int Braz J Urol 2016;42(4):710–6. DOI:10.1590/S16775538.IBJU.2014.0291.; Yuan D., Liu Y., Rao H. et al. Supine versus prone position in percutaneus nephrolithtomy for kidney calculi: a metaanalyses. J Endourol 2016;30(7):754–63. DOI:10.1089/end.2015.0402.; Ljungberg B., Albiges L., Bensalah K. et al. Guadelamus on Renal Cell Carcinoma. Eur Ass Urol 2017:24–5.; Алексеева Г.Н., Кику П.Ф., Юдин С.В. и др. Сравнительная оценка качества жизни больных раком почки после хирургического лечения. Бюллетень физиологии и патологии дыхания 2017;66:77–82.; Недошивин А.О., Кутузова А.Э., Петрова Н.Н. Исследование качества жизни и психологического статуса больных с хронической сердечной недостаточностью. Сердечная недостаточность 2000;4(1):23–6.; Даулетбакова Д.Н. Изучение качества жизни больных артериальной гипертензией на основании использования опросника SF-36. Молодой ученый 2018;23(209):23–8.; Пикалова Н.Н. Изучение качества жизни больных ХОБЛ в сочетании с ХСН на основании использования опросника SF-36. Вестник Новосибирского государственного педагогического университета 2012;3(7):85–94.; Шапавалов Р.Г., Силина Л.В., Бобынцев И.И. Исследование показателей качества жизни больных распространенным псориазом с использованием опросника SP-36. Вестник новых медицинских технологий 2011;ХVIII(1):90–3. [; Метько Е.Е., Полянская А.В. Опросник SF-36 как метод оценки качества жизни человека. Электронный научный журнал «Apriori. Серия: Естественные и технические науки» 2018;5. Доступно по: http://www.apriori-journal.ru/seria2/5-2018/Metiko-Polyanskaya.pdf; Амирджанова В.М., Горячев Д.В., Коршунов Н.И. и др. Популяционные показатели качества жизни по опроснику SF-36 (результаты многоцентрового исследования качества жизни «Мираж»). Научно-практическая ревматология 2008;1:36–48.; Попов С.В., Скрябин О.Н., Сулейманов М.М., Гусейнов Р.Г. Сравнительный анализ результатов ЭВХ нефронсохраняющих операций по поводу опухолей почек, выполненных в условиях тепловой ишемии органа и при сохранении его кровоснабжения. Врач-аспирант 2015;1(68):54–8.; https://oncourology.abvpress.ru/oncur/article/view/940

Availability: https://oncourology.abvpress.ru/oncur/article/view/940
https://doi.org/10.17650/1726-9776-2019-15-2-25-34

Practical aspects of treatment of kidney cancer in a modern hospital: the evolution of surgical approaches ; Практика лечения рака почки в условиях современного стационара: эволюция подходов

Authors: S. A. Rakul, K. V. Pozdnyakov, R. A. Eloev, N. A. Pliskachevskiy, С. А. Ракул, К. В. Поздняков, Р. А. Елоев, Н. А. Плискачевский

Source: Cancer Urology; Том 14, № 2 (2018); 44--53 ; Онкоурология; Том 14, № 2 (2018); 44--53 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2018-14-2

Subject Terms: осложнения, organ-preserving treatment, robot-assisted nephron sparing, complication, органсохраняющее лечение, робот-ассистированная резекция почки, лапароскопическая радикальная нефрэктомия

File Description: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/785/763; Jemal A., Bray F., Centr M.M. et al. Global cancer statistics. CA Cancer J Clin 2011;61(2):69–90. DOI:10.3322/caac.20107. PMID: 21296855.; Ferlay J., Soerjomataram I., Dikshit R. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136(5):E359–86. DOI:10.1002/ijc.29210. PMID: 25220842.; Злокачественные новообразования в России в 2015 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИРЦ» Минздрава России, 2017. 250 с.; Huang W.C., Elkin E.B., Levey A.S. et al. Partial nephrectomy versus radical nephrectomy in patients with small renal tumors – is there a difference in mortality and cardiovascular outcomes? J Urol 2009;181(1):55–61. DOI:10.1016/j.juro.2008.09.017. PMID: 19012918.; Kates M., Badalato G.M., Pitman M., McKiernan J.M. Increased risk of overall and cardiovascular mortality after radical nephrectomy for renal cell carcinoma 2 cm or less. J Urol 2011;186(4):1247–53. DOI:10.1016/j.juro.2011.05.054. PMID: 21849201.; Miller D.C., Schonlau M., Litwin M.S. et al. Renal and cardiovascular morbidity after partial or radical nephrectomy. Cancer 2008;112(3):511–20. DOI:10.1002/cncr.23218. PMID: 18072263.; Kutikov A., Smaldone M.C., Uzzo R.G. Partial versus radical nephrectomy: balancing nephrons and perioperative risk. Eur Urol 2013;64(4):607–9. DOI:10.1016/j.eururo.2013.01.020. PMID: 23375430.; Kaushik D., Kim S.P., Childs M.A. et al. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors. Eur Urol 2013;64(4):600–6. DOI:10.1016/j.eururo.2012.12.023. PMID: 23280319.; Ljungberg B., Hanbury D.C., Kuczyk M.A. et al. Renal cell carcinoma guideline. Eur Urol 2007;51(6):1502–10. DOI:10.1016/j.eururo.2007.03.035. PMID: 17408850.; Campbell S., Uzzo R.G., Allaf M.E. et al. Renal mass and localized renal cancer: AUA guideline. J Urol 2017;198(3):520–9. DOI:10.1016/j.juro.2017.04.100. PMID: 28479239.; Лоран О.Б., Серегин А.В., Шустицкий Н.А. Технические особенности при выполнении органосохраняющих операций по поводу рака почки. Медицинский вестник Башкортостана 2013;8(2):197–201. [; Волкова М.И., Скворцов И.Я., Климов А.В. и др. Влияние объема хирургического вмешательства на функциональные результаты и кардиоспецифическую выживаемость у больных клинически локализованным раком почки. Онкоурология 2014;(3):22–30. [; Алексеев Б.Я., Анжиганова Ю.В., Лыков А.В. и др. Особенности диагностики и лечения рака почки в России: предварительные результаты многоцентрового кооперированного исследования. Онкоурология 2012(3):24–30.; Clavien P.A., Barkun J., de Oliveira M.L. et al. The Clavien–Dindo classification of surgical complications: five year experience. Ann Surg 2009;250(2):187–96. DOI:10.1097/SLA.0b013e3181b13ca2. PMID: 19638912.; Olbert P.J., Maier M., Heers H. et al. Indications for nephron-sparing surgery. Analysis over a 13-year period in the context of changing guidelines. Urologe A 2015;54(6):804–10. DOI:10.1007/s00120-014-3710-2. PMID: 25503720.; Minervini A., Vittori G., Antonelli A. et al. Open versus robotic-assisted partial nephrectomy: a multicenter comparison study of perioperative results and complications. World J Urol 2014;32(1):287–93. DOI:10.1007/s00345-013-1136-x. PMID: 23913095.; Sun M., Abdollah F., Shariat S.F. et al. Propensity-score matched comparison of complications, blood transfusions, length of stay, and in-hospital mortality between open and laparoscopic partial nephrectomy: a national series. Eur J Surg Oncol 2012;38(1):80–7. DOI:10.1016/j.ejso.2011.09.035. PMID: 21996370.; Hadjipavlou M., Khan F., Fowler S. et al. Partial vs radical nephrectomy for T1 renal tumours: an analysis from the British Association of Urological Surgeons Nephrectomy Audit. BJU Int 2015;117(1):62–71. DOI:10.1111/bju.13114. PMID: 25754386.; Autorino R., Zargar H., Butler S. et al. Incidence and risk factors for 30-day readmission in patients undergoing nephrectomy procedures: a contemporary analysis of 5276 cases from the National Surgical Quality Improvement Program database. Urology 2015;85(4):843–9. DOI:10.1016/j.urology.2014.11.044. PMID: 25681252.; Meyer C., Hansen J., Becker A. et al. The adoption of nephron-sparing surgery in Europe – a trend analysis in two referral centers from Austria and Germany. Urol Int 2016;96(3):330–6. DOI:10.1159/000442215. PMID: 26699625.; Lista G., Buffi N.M., Lughezzani G. et al. Margin, ischemia, and complications system to report perioperative outcomes of robotic partial nephrectomy: a European Multicenter Observational Study (EMOS project). Urology 2015;85(3):589–95. DOI:10.1016/j.urology.2014.09.068. PMID: 25733270.; Mathieu R., Verhoest G., Droupy S. et al. Predictive factors of complications after robot-assisted laparoscopic partial nephrectomy: a retrospective multicentre study. BJU Int 2013;112(4):E283–9. DOI:10.1111/bju.12222. PMID: 23879913.; Nogueira L., Katz D., Pinochet R. et al. Critical evaluation of perioperative complications in laparoscopic partial nephrectomy. Urology 2010;75(2):288–94. DOI:10.1016/j.urology.2009.09.036. PMID: 19963244.; Alemozaffar M., Chang S.L., Kacker R. et al. Comparing costs of robotic, laparoscopic, and open partial nephrectomy. J Endourol 2013;27(5):560–5. DOI:10.1089/end.2012.0462. PMID: 23130756.; Mano R., Schulman A., Hakimi A.A. et al. Cost comparison of open and robotic partial nephrectomy using a short postoperative pathway. Urology 2015;85(3):596– 603. DOI:10.1016/j.urology.2014.10.044. PMID: 25586478.; https://oncourology.abvpress.ru/oncur/article/view/785

Availability: https://oncourology.abvpress.ru/oncur/article/view/785
https://doi.org/10.17650/1726-9776-2018-14-2-44--53

LAPAROSCOPIC THROMBECTOMY WITH RADICAL NEPHRECTOMY FOR RENAL CELL CARCINOMA WITH INFERIOR VENA CAVA THROMBUS ; ЛАПАРОСКОПИЧЕСКАЯ ТРОМБЭКТОМИЯ ИЗ НИЖНЕЙ ПОЛОЙ ВЕНЫ С РАДИКАЛЬНОЙ НЕФРЭКТОМИЕЙ ПРИ МЕСТНО-РАСПРОСТРАНЕННОМ ПОЧЕЧНО-КЛЕТОЧНОМ РАКЕ

Authors: D. V. Perlin, V. P. Zipunnikov, I. N. Dymkov, A. O. Shmanev, M. B. Popova, Д. В. Перлин, В. П. Зипунников, И. Н. Дымков, А. О. Шманев, М. Б. Попова

Source: Urology Herald; № 4 (2016); 5-14 ; Вестник урологии; № 4 (2016); 5-14 ; 2308-6424 ; 10.21886/2308-6424-2016-0-4

Subject Terms: нижняя полая вена, laparoscopic radical nephrectomy, thrombectomy, vena cava inferior, лапароскопическая радикальная нефрэктомия, тромбэктомия

File Description: application/pdf

Relation: https://www.urovest.ru/jour/article/view/106/102; Hatcher PA, Anderson EE, Paulson DFF, Robertson JE. Surgical prognosis and management of renal carcinoma invading the inferior vena cava. J Urol 1991, 145:20-23; Алексеев Б.Я., Калпинский А.С., Каприн А.Д., Костин А.А. Роль бевацизумаба в лечении метастатического почечно-клеточного рака. Онкоурология 2009, 4: 68-73; Давыдов М.И., Матвеев В.Б., Феоктистов П.И., Жужгинова О.В. и др. Факторы прогноза непосредственных результатов тромбэктомии у больных раком почки с опухолевым венозным тромбозом. Онкоурология 2014, 3: 36 – 44; Sundaram CP, Rehman J, Landman J, Oh J. Hand assisted laparoscopic radical nephrectomy for renal cell carcinoma with inferior vena caval thrombus. J. Urol. 2002, 168 (1): 176-179; Romero FR, Muntener M, Bagga HS, Brito FA, et al. Pure laparoscopic radical nephrectomy with level II vena caval thrombectomy. Urology 2006, 68 (5): 1112-1114; Lee J.Y, Mucksavage P. Robotic radical nephrectomy with vena caval tumor thrombectomy: experience of novice robotic surgeons. Korean J Urol 2012, 53 (12): 879-882; Wang M, Ping H, Niu Y, Zhang J, Xing N. Pure conventional laparoscopic radical nephrectomy with level II vena cava tumor thrombectomy. Int .Braz. J. Urol 2014, 40 (2): 266-273; Abaza R. Technical considerations in robotic nephrectomy with vena caval tumor thrombectomy. Indian J. Urol. 2014, 30 (3): 283-286; Perlin D, Alexandrov I, Zipunnikov V, Sapozhnikov A. et al. Laparoscopic radical nephrectomy with inferior vena cava thrombectomy. J. Endourology 2014, 28 (1): 277-278; Varkarakis IM, Bhayani SB, Allaf ME, Inagaki T. et al. Laparoscopic-assisted nephrectomy with inferior vena cava tumor thrombectomy: preliminary results. Urology 2004, 64 (5): 925-929; https://www.urovest.ru/jour/article/view/106

Availability: https://www.urovest.ru/jour/article/view/106
https://doi.org/10.21886/2308-6424-2016-0-4-5-14

LYMPH NODE DISSECTION IN PATIENTS WITH RENAL-CELL CARCINOMA OF THE PROS AND CONS ; ЛИМФОДИССЕКЦИЯ У ПАЦИЕНТОВ С ПОЧЕЧНО-КЛЕТОЧНЫМ РАКОМ ЗА И ПРОТИВ

Authors: S. V. Shkodkin, Y. B. Idashkin, A. V. Lyubushkin, S. A. Fironov, С. В. Шкодкин, Ю. Б. Идашкин, А. В. Любушкин, С. А. Фиронов

Source: Urology Herald; № 4 (2015); 43-49 ; Вестник урологии; № 4 (2015); 43-49 ; 2308-6424 ; 10.21886/2308-6424-2015-0-4

Subject Terms: лимфодиссекция, radical nephrectomy, lymphadenectomy, радикальная нефрэктомия

File Description: application/pdf

Relation: https://www.urovest.ru/jour/article/view/14/16; Клиническая онкоурология (под редакцией профессора Б.П. Матвеева), Москва 2011, стр. 56.; Опухоли мочеполовой системы (под редакцией профессора Ю.Г. Аляе- ва), Москва «Геотар-Медиа», стр. 439.; EAU Full Guideline Renal cell carcinoma, - 2015 p. 24.; Bekema HJ, MacLennan S, Imamura M, et al. Systematic review of adrenalectomy and lymph node dissection in locally advanced renal cell carcinoma. Eur Urol 2013 Nov;64(5):799-810. http://www.ncbi.nlm.nih.gov/pubmed/23643550; Blom JH, Van Poppel H, Marйchal JM, et al. Radical Nephrectomy with and without Lymph-Node-Dissection: Final Results of European Organization for Research and Treatment of Cancer (EORTC) Randomized Phase 3 Trial 30881. Eur Urol 2009 Jan;55(1):28-34. http://www.ncbi.nlm.nih.gov/pubmed/18848382; Tsui KH, Shvarts O, Smith RB, et al. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J Urol 2000;163:1090-5. quiz 1295. http://www.ncbi.nlm.nih.gov/ pubmed/10737472.; Capitanio U, Becker F, Blute ML, et al. Lymph node dissection in renal cell carcinoma. Eur Urol 2011 Dec;60(6):1212-20. http://www.ncbi.nlm.nih.gov/pubmed/ 21940096.; Babaian KN, Kim DY, Kenney PA, Wood CG Jr, Wong J, Sanchez C, Fang JE, Gerber JA, Didic A, Wahab A, Golla V, Torres C, Tamboli P, Qiao W, Matin SF, Wood CG, Karam JA. Preoperative predictors of pathological lymph node metastasis in patients with renal cell carcinoma undergoing retroperitoneal lymph node dissection. J Urol. 2015 Apr;193(4):1101-7. doi:10.1016/j.juro.2014.10.096. Epub 2014 Oct 25. PMID: 25390078; Capitanio U, Suardi N, Matloob R, Roscigno M, Abdollah F, Di Trapani E, Moschini M, Gallina A, Salonia A, Briganti A, Montorsi F, Bertini R. Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC). BJU Int. 2014 Aug;114(2):210-5. doi:10.1111/bju.12508. Epub 2014 May 22. PMID: 24854206; Barrisford GW, Gershman B, Blute ML Sr. The role of lymphadenectomy in the management of renal cell carcinoma. World J Urol. 2014 Jun;32(3):643-9. doi:10.1007/s00345-014-1294-5. Epub 2014 Apr 11. Review. PMID: 24723269; https://www.urovest.ru/jour/article/view/14

Availability: https://www.urovest.ru/jour/article/view/14
https://doi.org/10.21886/2308-6424-2015-0-4-43-49

Neoadjuvant targeted therapy in patients with renal cell carcinoma ; Неоадъювантная таргетная терапия у больных почечно-клеточным раком

Authors: B. Ya. Alekseev, K. M. Nyushko, A. S. Kalpinsky, Б. Я. Алексеев, К. М. Нюшко, А. С. Калпинский

Source: Cancer Urology; Том 11, № 2 (2015); 23-33 ; Онкоурология; Том 11, № 2 (2015); 23-33 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2015-11-2

Subject Terms: неоадъювантная таргетная терапия, metastatic renal cell carcinoma, cytoreductive nephrectomy, radical nephrectomy, targeted therapy, sorafenib, sunitinib, bevacizumab, axitinib, pazopanib, neoadjuvant targeted therapy, метастатический почечно-клеточный рак, циторедуктивная нефрэктомия, радикальная нефрэктомия, таргетная терапия, сорафениб, сунитиниб, бевацизумаб, акситиниб, пазопаниб

File Description: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/450/433; International Agency for Research on Cancer. The GLOBOCAN project: cancer incidence and mortality worldwide in 2012. Доступно по адресу: http://globocan.iarc.fr/; Злокачественные новообразования в России в 2013 году: заболеваемость и смертность. Под ред. А. Д. Каприна, В. В. Старинского, Г. В. Петровой. М., 2015. [Malignant neoplasms in Russia in 2013: morbidity and mortality. Ed. A. D. Caprin, V. V. Starinskiy, G. V. Petrova. Moscow, 2015. (In Russ.)].; Flanigan R.C., Yonover P.M. The role of radical nephrectomy in metastatic renal cell carcinoma. Semin Urol Oncol ;19(2):98–102.; Bex A., Powles T. Selecting patients for cytoreductive nephrectomy in advanced renal cell carcinoma: who and when. Expert Rev. Anticancer Ther 2012; 12(6):787–97.; Flanigan R. C., Salmon S. E., Blumenstein B. A. et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renalcell cancer. N Engl J Med 2001;345(23):1655–9.; Mickisch G. H., Garin A., Van Poppel H. et al. Radical nephrectomy plus interferonalfa- based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet 2001;358(9286):966–70.; Flanigan R. C., Mickisch G., Sylvester R. et al. Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis. J Urol 2004;171:1071–6.; Motzer R. J., Bukowski R. M., Figlin R. A. et al. Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma. Cancer 2008;113(7): 1552–8.; Wood C. G. Multimodal approaches in the management of locally advanced and metastatic renal cell carcinoma: combining surgery and systemic therapies to improve patient outcome. Clin Cancer Res 2001; 13(2 Pt 2):697–702.; Zini L., Capitanio U., Perrotte P. et al. Population-based assessment of survival after cytoreductive nephrectomy versus no surgery in patients with metastatic renal cell carcinoma. Urology 2009;73(2): 342–6.; Choueiri T. K., Xie W., Kollmannsberger C. et al. The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapy. J Urol 2011;185(1):60–6.; Warren M., Venner P. M., North S. et al. A population-based study examining the effect of tyrosine kinase inhibitors on survival in metastatic renal cell carcinoma in Alberta and the role of nephrectomy prior to treatment. Can Urol Assoc J 2001;3(4):281–9.; Aben K. K., Heskamp S., Janssen-Heijnen M. L. et al. Better survival in patients with metastasised kidney cancer after nephrectomy: a population-based study in the Netherlands. Eur J Cancer 2011;47(13):2023–32.; Kutikov A., Uzzo R. G., Caraway A. et al. Use of systemic therapy and factors affecting survival for patients undergoing cytoreductive nephrectomy. BJU Int 2010;106(2):218–23.; Abdollah F., Sun M., Thuret R. et al. Mortality and morbidity after cytoreductive nephrectomy for metastatic renal cell carcinoma: a population-based study. Ann Surg Oncol 2011;18(10):2988–96.; Mizutani Y. Recent advances in molecular targeted therapy for metastatic renal cell carcinoma. Int J Urol 2009;16:444–8.; Sonpavde G., Sternberg C. N. Neoadjuvant systemic therapy for urological malignancies. BJU Int 2010;106:6–22.; Shuch B., Riggs S. B., LaRochelle J.C. et al. Neoadjuvant targeted therapy and advanced kidney cancer: observations and implications for a new treatment paradigm. BJU Int 2008;102:692–6.; Schrader A. J., Steffens S., Schnoeller T. J. et al. Neoadjuvant therapy of renal cell carcinoma: A novel treatment option in the era of targeted therapy? Int J Urol 2012;19:903–7.; Silberstein J. L., Millard F., Mehrazin R. et al. Feasibility and efficacy of neoadjuvant sunitinib before nephron-sparing surgery. BJU Int 2010;106:1270–6.; Hellenthal N. J., Underwood W., Penetrante R. et al. Prospective clinical trial of preoperative sunitinib in patients with renal cell carcinoma. J Urol 2010;184:859–64.; Bex A., van der Veldt A. A., Blank C. et al. Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery. World J Urol 2009;27:533–9.; Powles T., Kayani I., Blank C. et al. The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer. Ann Oncol 2011;22: 1041–7.; Margulis V., Matin S. F., Tannir N. et al. Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma. J Urol 2008;180:94–8.; Chapin B. F., Delacroix S. E.Jr, Culp S. H. et al. Safety of presurgical targeted therapy in the setting of metastatic renal cell carcinoma. Eur Urol 2011;60:964–71.; Wood C. G., Margulis V. Neoadjuvant (presurgical) therapy for renal cell carcinoma: a new treatment paradigm for locally advanced and metastatic disease. Cancer 2009;115:2355–60.; Abel E. J., Culp S. H., Tannir N. M. et al. Primary tumor response to targeted agents in patients with metastatic renal cell carcinoma. Eur Urol 2011;59:10–5.; Harshman L. C., Yu R. J., Allen G. I. et al. Surgical outcomes and complications associated with presurgical tyrosine kinase inhibition for advanced renal cell carcinoma (RCC). Urol Oncol 2011.; Karakiewicz P. I., Suardi N., Jeldres C. et al. Neoadjuvant sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi. Eur Urol 2008;53:845–8.; Di Silverio F., Sciarra A., Parente U. et al. Neoadjuvant therapy with sorafenib in advanced renal cell carcinoma with vena cava extension submitted to radical nephrectomy. Urol. Int. 2008;80: 451–3.; Kondo T., Hashimoto Y., Kobayashi H. et al. Presurgical targeted therapy with tyrosine kinase inhibitors for advanced renal cell carcinoma: clinical results and histopathological therapeutic effects. Jpn J Clin Oncol 2010;40:1173–9.; Harshman L. C., Srinivas S., Kamaya A., Chung B. I. Laparoscopic radical nephrectomy after shrinkage of a caval tumor thrombus with sunitinib. Nat Rev Urol 2009;6:338–43.; Robert G., Gabbay G., Bram R. et al. Case study of the month. Complete histologic remission after sunitinib neoadjuvant therapy in T3b renal cell carcinoma. Eur Urol 2009;55:1477–80.; Bex A., van der Veldt A. A., Blank C. et al. Progression of a caval vein thrombus in two patients with primary renal cell carcinoma ыon pretreatment with sunitinib. Acta Oncol 2010;49:520–3.; Cost N. G., Delacroix S. E.Jr, Sleeper J. P. et al. The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus. Eur Urol 2011;59:912–8.; Cowey C. L., Amin C., Pruthi R. S. et al. Neoadjuvant clinical trial with sorafenib for patients with stage II or higher renal cell carcinoma. J Clin Oncol 2010;28:1502–7.; Thomas A. A., Rini B. I., Stephenson A. J. et al. Surgical resection of renal cell carcinoma after targeted therapy. J Urol 2009;182(3):881–6.; Amin C., Wallen E., Pruthi R. S. et al. Preoperative tyrosine kinase inhibition as an adjunct to debulking nephrectomy. Urology 2008;72(4):864–8.; Jonasch E., Wood C. G., Matin S. F. et al. Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma. J Clin Oncol 2009;27:4076–81.; Powles T., Sarwar N., Stockdale A. et al. Pazopanib prior to planned nephrectomy in metastatic clear cell renal cancer: A clinical and biomarker study. J Clin Oncol 2013;31 (suppl; abstr 4508).; Rini B. I., Plimack E. R., Takagi T. et al. A phase ii study of pazopanib in patients with localized renal cell carcinoma to optimize preservation of renal parenchyma. J Urol 2015 Mar 23. pii: S0022–5347(15) 03398–4.; Alvarez A. L., Plimack E. R., Dreicer R. et al. A phase II study of pazopanib in patients with localized renal cell carcinoma to enable partial nephrectomy. J Clin Oncol 2014;32:5 (suppl; abstr 4522).; Karam J. A., Devine C. E., Urbauer D. L. et al. Phase II trial of neoadjuvant axitinib in patients with locally advanced nonmetastatic clear cell renal cell carcinoma. J Clin Oncol (Meeting Abstracts) 2014;32:441.; Lane B. R., Derweesh I. H., Kim H. L. et al. Presurgical sunitinib reduces tumor size and may facilitate partial nephrectomy in patients with renal cell carcinoma. Urol Oncol 2015;33(3):112. e15–21.; https://oncourology.abvpress.ru/oncur/article/view/450

Availability: https://oncourology.abvpress.ru/oncur/article/view/450
https://doi.org/10.17650/1726-9776-2015-11-2-23-33

Мультимодальное лечение двусторонних опухолей почек как способ улучшения онкологических и функциональных результатов: клинический случай и обзор литературы

Authors: JENNIFER YATES, RAVI MUNVER, DAVID CRAWLEY, THOMAS CHRISTIANO, IHOR SAWCZUK

Source: Malignant tumours; Том 1, № 1 (2011); 21-28 ; Злокачественные опухоли; Том 1, № 1 (2011); 21-28 ; 2587-6813 ; 2224-5057

Subject Terms: радикальная нефрэктомия., синхронный, опухоль почки, почечно-клеточный рак, объемные образования в почке, криотерапия, резекция почки

File Description: application/pdf

Relation: https://www.malignanttumors.org/jour/article/view/141/146; Jemal, A., Siegal, R., Ward E.: Cancer Statistics. A Cancer Journal for Clinicians, caac.20006v2, 5-27-2009; Chow, W. H., Devesa, S. S., Warren, J. L., Fraumeni, J. F., Jr.: Rising incidence of renal cell cancer in the United States. JAMA, 281: 1628, 1999; Hollingsworth, J. M., Miller, D. C., Daignault, S., Hollenbeck, B. K.: Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst, 98: 1331, 2006; Lopez-Beltran, A., Carrasco, J. C., Cheng, L., Scarpelli, M., Kirkali, Z., Montironi, R.: 2009 update on the classification of renal epithelial tumors in adults. Int J Urol, 16: 432, 2009; Linehan, W. M.: Genetic basis of bilateral renal cancer: implications for evaluation and management. J Clin Oncol, 27: 3731, 2009; Boris, R., Proano, M., Linehan, W. M., Pinto, P. A., Bratslavsky, G.: Initial experience with robot assisted partial nephrectomy for multiple renal masses. J Urol, 182: 1280, 2009; Linehan, W. M., Vasselli, J., Srinivasan, R., Walther, M. M., Merino, M., Choyke, P. et al.: Genetic basis of cancer of the kidney: disease-specific approaches to therapy. Clin Cancer Res, 10: 6282S, 2004; Rosner, B., Polk, B. F.: The implications of blood pressure variability for clinical and screening purposes. J Chronic Dis, 32: 451, 1979; Feldman, D. R., Motzer, R. J.: Novel targets and therapies for metastatic renal cell carcinoma. Oncology (Williston Park), 20: 1745, 2006; Kruck, S., Merseburger, A. S., Gakis, G., Kramer, M. W., Stenzl, A., Kuczyk, M. A.: An update on the medical therapy of advanced metastatic renal cell carcinoma. Scand J Urol Nephrol, 42: 501, 2008; Rini, B. I., Bukowski, R. M.: Targeted therapy for metastatic renal cell carcinoma: a home run or a work in progress? Oncology (Williston Park), 22: 388, 2008; Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., Hsu, C. Y.: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med, 351: 1296, 2004; Huang, W. C., Levey, A. S., Serio, A. M., Snyder, M., Vickers, A. J., Raj, G. V. et al.: Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol, 7: 735, 2006; Huang, W. C., Elkin, E. B., Levey, A. S., Jang, T. L., Russo, P.: Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes? J Urol, 181: 55, 2009; Thompson, R. H., Boorjian, S. A., Lohse, C. M., Leibovich, B. C., Kwon, E. D., Cheville, J. C. et al.: Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol, 179: 468, 2008; Weiner, D. E., Tabatabai, S., Tighiouart, H., Elsayed, E., Bansal, N., Griffith, J. et al.: Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis, 48: 392, 2006; Koenig, P., Gill, I.S., Kamoi K., Aron, M., Haber, G., Singh, A.B., Weight, CJ, Desai, MM, Kaouk, JH, Goldfarb, DA, Poggio, E.D.: Kidney cancer and the risk for chronic kidney disease: matched-paired comparison with living donors. The Journal of Urology, 179: 170, April 2008; McKiernan, J., Simmons, R., Katz, J., Russo, P.: Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology, 59: 816, 2002; System, U. S. R. D.: Annual Data Report. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), and US Department of Health and Human Services (DHHS). 2007; Foley, R. N., Parfrey, P. S., Sarnak, M. J.: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis, 32: S112, 1998; Rocco, M., Frankenfield, DL, Hopson SK, McClellan WM: Relationship between clinical performance measures and outcomes among patients receiving long-term hemodialysis. Ann. Intern. Med, 145: 512, 2006; Neil, N., Guest, S., Wong, L., Inglese, G., Bhattacharyya, S. K., Gehr, T. et al.: The financial implications for Medicare of greater use of peritoneal dialysis. Clin Ther, 31: 880, 2009; Kasiske, B. L., Cangro, C. B., Hariharan, S., Hricik, D. E., Kerman, R. H., Roth, D. et al.: The evaluation of renal transplantation candidates: clinical practice guidelines. Am J Transplant, 1 Suppl 2: 3, 2001; Lin, S. J., et al.: The association between length of post-kidney transplant hospitalization and long-term graft and recipient survival. Clin. Transplant, 20: 245, 2006; Campbell, S. C., Novick, A. C., Belldegrun, A., Blute, M. L., Chow, G. K., Derweesh, I. H. et al.: Guideline for management of the clinical T1 renal mass. J Urol, 182: 1271, 2009; Leibovich, B. C., Blute, M. L., Cheville, J. C., Lohse, C. M., Weaver, A. L., Zincke, H.: Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J Urol, 171: 1066, 2004; Touijer, K., Jacqmin, D., Kavoussi, L. R., Montorsi, F., Patard, J. J., Rogers, C. G. et al.: The expanding role of partial nephrectomy: a critical analysis of indications, results, and complications. Eur Urol, 57: 214, 2010; Gupta, G. N., Peterson, J., Thakore, K. N., Pinto, P. A., Linehan, W. M., Bratslavsky, G.: Oncological Outcomes of Partial Nephrectomy for Multifocal Renal Cell Carcinoma Greater Than 4 cm. J Urol, 2010; Dash, A., Vickers, A. J., Schachter, L. R., Bach, A. M., Snyder, M. E., Russo, P.: Comparison of outcomes in elective partial vs radical nephrectomy for clear cell renal cell carcinoma of 4-7 cm. BJU Int, 97: 939, 2006; Breau, R. H., Crispen, P. L., Jimenez, R. E., Lohse, C. M., Blute, M. L., Leibovich, B. C.: Outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy. J Urol, 183: 903, 2010; Woldu, S. L., Barlow, L. J., Patel, T., Hruby, G. W., Benson, M. C., McKiernan, J. M.: Single Institutional Experience with Nephron-sparing Surgery for Pathologic Stage T3bNxM0 Renal Cell Carcinoma Confined to the Renal Vein. Urology, 2010; Kolla, S. B., Ercole, C., Spiess, P. E., Pow-Sang, J. M., Sexton, W. J.: Nephron-sparing surgery for pathological stage T3b renal cell carcinoma confined to the renal vein. BJU Int, 2010; Kaul, S., Laungani, R., Sarle, R., Stricker, H., Peabody, J., Littleton, R. et al.: da Vinci-assisted robotic partial nephrectomy: technique and results at a mean of 15 months of follow-up. Eur Urol, 51: 186, 2007; Ho, H., Schwentner, C., Neururer, R., Steiner, H., Bartsch, G., Peschel, R.: Robotic-assisted laparoscopic partial nephrectomy: surgical technique and clinical outcomes at 1 year. BJU Int, 103: 663, 2009; Gettman, M. T., Blute, M. L., Chow, G. K., Neururer, R., Bartsch, G., Peschel, R.: Robotic-assisted laparoscopic partial nephrectomy: technique and initial clinical experience with DaVinci robotic system. Urology, 64: 914, 2004; Caruso, R. P., Phillips, C. K., Kau, E., Taneja, S. S., Stifelman, M. D.: Robot assisted laparoscopic partial nephrectomy: initial experience. J Urol, 176: 36, 2006; Phillips, C. K., Taneja, S. S., Stifelman, M. D.: Robotassisted laparoscopic partial nephrectomy: the NYU technique. J Endourol, 19: 441, 2005; Michli, E. E., Parra, R. O.: Robotic-assisted laparoscopic partial nephrectomy: initial clinical experience. Urology, 73: 302, 2009; Deane, L. A., Lee, H. J., Box, G. N., Melamud, O., Yee, D. S., Abraham, J. B. et al.: Robotic versus standard laparoscopic partial/wedge nephrectomy: a comparison of intraoperative and perioperative results from a single institution. J Endourol, 22: 947, 2008; Rogers, C. G., Metwalli, A., Blatt, A. M., Bratslavsky, G., Menon, M., Linehan, W. M. et al.: Robotic partial nephrectomy for renal hilar tumors: a multi-institutional analysis. J Urol, 180: 2353, 2008; Rogers, C. G., Singh, A., Blatt, A. M., Linehan, W. M., Pinto, P. A.: Robotic partial nephrectomy for complex renal tumors: surgical technique. Eur Urol, 53: 514, 2008; Gill, I. S., Kavoussi, L. R., Lane, B. R., Blute, M. L., Babineau, D., Colombo, J. R., Jr. et al.: Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol, 178: 41, 2007; Aron, M., Koenig, P., Kaouk, J. H., Nguyen, M. M., Desai, M. M., Gill, I. S.: Robotic and laparoscopic partial nephrectomy: a matched-pair comparison from a highvolume centre. BJU Int, 102: 86, 2008; Wang, A. J., Bhayani, S. B.: Robotic partial nephrectomy versus laparoscopic partial nephrectomy for renal cell carcinoma: single-surgeon analysis of >100 consecutive procedures. Urology, 73: 306, 2009; Kutikov, A., Uzzo, R. G.: The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol, 182: 844, 2009; Boris, R. S., Sanford, T., Pinto, P.A, Linehan M.L., Bratslavsky G.: Off-clamp robot assisted partial nephrectomy for multifocal renal masses in the hereditary renal population. Journal of Urology, 183: e370, April 2010; Chung, P. H., Gupta G., Boris R.S.,Linehan W.M., Pinto P.A., Bratslavsky G.: Robot assisted laparoscopic partial nephrectomy for tumors greater than 4cm: Feasibility and early functional outcomes. Journal of Urology, 183: e355, April 2010; White, W. M., Haber, G. P., Goel, R. K., Crouzet, S., Stein, R. J., Kaouk, J. H.: Single-port urological surgery: single-center experience with the first 100 cases. Urology, 74: 801, 2009; Haber, G. P., Crouzet, S., Kamoi, K., Berger, A., Aron, M., Goel, R. et al.: Robotic NOTES (Natural Orifice Translumenal Endoscopic Surgery) in reconstructive urology: initial laboratory experience. Urology, 71: 996, 2008; Lee, B. R., Wolf, J. S., Jr.: Natural orifice transluminal endoscopic surgery (NOTES) partial nephrectomy. B. R. Lee, U. Boylu, M. Oommen, G. Fifer, R. Thomas and V. Joshi. J Urol, 183: 1731, 2010; Carraway, W. A., Raman, J. D., Cadeddu, J. A.: Current status of renal radiofrequency ablation. Curr Opin Urol, 19: 143, 2009; Pasticier, G., Timsit, M. O., Badet, L., De La Torre Abril, L., Halila, M., Fassi Fehri, H. et al.: Nephron-sparing surgery for renal cell carcinoma: detailed analysis of complications over a 15-year period. Eur Urol, 49: 485, 2006; Committee., A. P. G.: Chapter 1: Management of the clinical stage 1 renal mass: diagnosis and treatment recommendations. AUA guideline for management of the clinical stage 1 renal mass: 1, 2009; Zagoria, R. J., Hawkins, A. D., Clark, P. E., Hall, M. C., Matlaga, B. R., Dyer, R. B. et al.: Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success. AJR Am J Roentgenol, 183: 201, 2004; Raman, J. D., Raj, G. V., Lucas, S. M., Williams, S. K., Lauer, E. M., Ahrar, K. et al.: Renal functional outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques. BJU Int, 105: 496, 2010; Park, S., Anderson, J. K., Matsumoto, E. D., Lotan, Y., Josephs, S., Cadeddu, J. A.: Radiofrequency ablation of renal tumors: intermediate-term results. J Endourol, 20: 569, 2006; McDougal, W. S., Gervais, D. A., McGovern, F. J., Mueller, P. R.: Long-term followup of patients with renal cell carcinoma treated with radio frequency ablation with curative intent. J Urol, 174: 61, 2005; Levinson, A. W., Su, L. M., Agarwal, D., Sroka, M., Jarrett, T. W., Kavoussi, L. R. et al.: Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass. J Urol, 180: 499, 2008; Gervais, D. A., McGovern, F. J., Arellano, R. S., McDougal, W. S., Mueller, P. R.: Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology, 226: 417, 2003; Malcolm, J. B., Berry, T. T., Williams, M. B., Logan, J. E., Given, R. W., Lance, R. S. et al.: Single center experience with percutaneous and laparoscopic cryoablation of small renal masses. J Endourol, 23: 907, 2009; Weld, K. J., Figenshau, R. S., Venkatesh, R., Bhayani, S. B., Ames, C. D., Clayman, R. V. et al.: Laparoscopic cryoablation for small renal masses: three-year follow-up. Urology, 69: 448, 2007; Lawatsch, E. J., Langenstroer, P., Byrd, G. F., See, W. A., Quiroz, F. A., Begun, F. P.: Intermediate results of laparoscopic cryoablation in 59 patients at the Medical College of Wisconsin. J Urol, 175: 1225, 2006; Gill, I. S., Remer, E. M., Hasan, W. A., Strzempkowski, B., Spaliviero, M., Steinberg, A. P. et al.: Renal cryoablation: outcome at 3 years. J Urol, 173: 1903, 2005; Aron, M., Kamoi, K., Remer, E., Berger, A., Desai, M., Gill, I.: Laparoscopic renal cryoablation: 8-year, single surgeon outcomes. J Urol, 183: 889, 2010; Stone, M. J., Venkatesan, A. M., Locklin, J., Pinto, P., Linehan, M., Wood, B. J.: Radiofrequency ablation of renal tumors. Tech Vasc Interv Radiol, 10: 132, 2007; Grimaldi, G., Reuter, V., Russo, P.: Bilateral non-familial renal cell carcinoma. Ann Surg Oncol, 5: 548, 1998; Klatte, T., Wunderlich, H., Patard, J. J., Kleid, M. D., Lam, J. S., Junker, K. et al.: Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience. BJU Int, 100: 21, 2007; Siemer, S., Uder, M., Zell, A., Ponicke, C., Humke, U., Ziegler, M. et al.: [Bilateral kidney tumor. Therapy management and histopathological results with long-term follow-up of 66 patients]. Urologe A, 40: 114, 2001; Zincke, H., Swanson, S. K.: Bilateral renal cell carcinoma: influence of synchronous and asynchronous occurrence on patient survival. J Urol, 128: 913, 1982; Blute, M. L., Itano, N. B., Cheville, J. C., Weaver, A. L., Lohse, C. M., Zincke, H.: The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma. J Urol, 169: 1276, 2003; Boorjian, S. A., Uzzo, R. G.: The evolving management of small renal masses. Curr Oncol Rep, 11: 211, 2009 Bratslavsky G, Boris RS.; Wunderlich, H. e. a.: Multifocality in renal cell carcinoma: A bilateral event? Urol. Int., 63: 160, 1999; Kowalczyk, K. J., Hooper, H. B., Linehan, W. M., Pinto, P. A., Wood, B. J., Bratslavsky, G.: Partial nephrectomy after previous radio frequency ablation: the National Cancer Institute experience. J Urol, 182: 2158, 2009; Hwang, J. J., Walther, M. M., Pautler, S. E., Coleman, J. A., Hvizda, J., Peterson, J. et al.: Radio frequency ablation of small renal tumors:: intermediate results. J Urol, 171: 1814, 2004; Walther, M. C., Shawker, T. H., Libutti, S. K., Lubensky, I., Choyke, P. L., Venzon, D. et al.: A phase 2 study of radio frequency interstitial tissue ablation of localized renal tumors. J Urol, 163: 1424, 2000; Johnson, A., Sudarshan, S., Liu, J., Linehan, W. M., Pinto, P. A., Bratslavsky, G.: Feasibility and outcomes of repeat partial nephrectomy. J Urol, 180: 89, 2008; Ghavamian, R., Cheville, J. C., Lohse, C. M., Weaver, A. L., Zincke, H., Blute, M. L.: Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery. J Urol, 168: 454, 2002; Saranchuk, J. W., Touijer, A. K., Hakimian, P., Snyder, M. E., Russo, P.: Partial nephrectomy for patients with a solitary kidney: the Memorial Sloan-Kettering experience. BJU Int, 94: 1323, 2004; Thompson, R. H., Leibovich, B. C., Lohse, C. M., Zincke, H., Blute, M. L.: Complications of contemporary open nephron sparing surgery: a single institution experience. J Urol, 174: 855, 2005; Magera, J. S., Jr., Frank, I., Lohse, C. M., Leibovich, B. C., Cheville, J. C., Blute, M. L.: Analysis of repeat nephron sparing surgery as a treatment option in patients with a solid mass in a renal remnant. J Urol, 179: 853, 2008; Stephenson, A. J., Hakimi, A. A., Snyder, M. E., Russo, P.: Complications of radical and partial nephrectomy in a large contemporary cohort. J Urol, 171: 130, 2004; Herring, J. C., Enquist, E. G., Chernoff, A., Linehan, W. M., Choyke, P. L., Walther, M. M.: Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience. J Urol, 165: 777, 2001; Bratslavsky, G., Liu, J. J., Johnson, A. D., Sudarshan, S., Choyke, P. L., Linehan, W. M. et al.: Salvage partial nephrectomy for hereditary renal cancer: feasibility and outcomes. J Urol, 179: 67, 2008; Nguyen, C. T., Lane, B. R., Kaouk, J. H., Hegarty, N., Gill, I. S., Novick, A. C. et al.: Surgical salvage of renal cell carcinoma recurrence after thermal ablative therapy. J Urol, 180: 104, 2008; Rogers, C. G., Menon, M, Weise, E., Gettman, M., Frank, I.,Shepard, D., et al.: Robotic partial nephrectomy: a multi-institutional analysis. Journal of Robotic Surgery, 2: 141, 2008; Benway, B. M., Wang, A. J., Cabello, J. M., Bhayani, S. B.: Robotic partial nephrectomy with sliding-clip renorrhaphy: technique and outcomes. Eur Urol, 55: 592, 2009; Liu, N. W., Khurana, K., Sudarshan, S., Pinto, P. A., Linehan, W. M., Bratslavsky, G.: Repeat partial nephrectomy on the solitary kidney: surgical, functional and oncological outcomes. J Urol, 183: 1719, 2010; https://www.malignanttumors.org/jour/article/view/141

Availability: https://www.malignanttumors.org/jour/article/view/141
https://doi.org/10.18027/2224-5057-2011-1-21-28

ЛИМФОДИССЕКЦИЯ У ПАЦИЕНТОВ С ПОЧЕЧНО-КЛЕТОЧНЫМ РАКОМ ЗА И ПРОТИВ

Authors: ШКОДКИН С.В., ИДАШКИН Ю.Б., ЛЮБУШКИН А.В., ФИРОНОВ С.А.

Subject Terms: ПОЧЕЧНО-КЛЕТОЧНЫЙ РАК,RENAL CELL CARCINOMA,РАДИКАЛЬНАЯ НЕФРЭКТОМИЯ,RADICAL NEPHRECTOMY,ЛИМФОДИССЕКЦИЯ,LYMPHADENECTOMY

File Description: text/html

Availability: http://cyberleninka.ru/article/n/limfodissektsiya-u-patsientov-s-pochechno-kletochnym-rakom-za-i-protiv
http://cyberleninka.ru/article_covers/16976830.png